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1 INTRODUCTION  
 
Every second we are subject to attack by various pathogenic microbes trying to invade our 
bodies and infect organs and tissues. Though at constant risk, the occurrence of an established 
infection is rare - proof of an efficient protective system. In addition to physical barriers such 
as skin and mucosa, a highly specialized network of cells and soluble factors, called the 
immune system, is the key feature of host defense. In higher organisms such as vertebrates 
(especially mammals and birds) the unspecific innate immune system is complemented by an 
antigen-specific adaptive compartment providing a more versatile means of defense. If 
protection fails, pathogens establish a focus of infection from which they can spread and 
sometimes cause fatal disease. This could be either because of the pathogen using strategies 
to elude or overcome the immune mechanisms or because of inborn (primary) or acquired 
(secondary) immunodeficiency. 
Edward Jenner’s breakthrough smallpox vaccination in 1796 and Robert Koch’s postulates 
on the criteria characterizing infectious disease in the late 19th century, paved the way for 
extensive research on the nature of infection and host defense, bringing to light valuable 
insights in immune system processes (SILVERSTEIN 1979a). In 1884 Elie Metchnikoff 
identified phagocytic cells as the key players in unspecific immunity (METCHNIKOFF 
1884). These cells, which he termed macrophages and microphages (neutrophils), were able 
to engulf and digest microbes. At this time the community of immunologists was split in two 
schools, the cellularists, headed by Metchnikoff and Louis Pasteur, and the humoralists, who 
hypothesized that immunity is mediated solely by soluble factors (SILVERSTEIN 1979b). 
The latter of theories was supported by Emil von Behring and Shibasaburo Kitasato who 
found evidence for the existence of antibodies and were the first to use antiserum to treat 
active disease. We now know that both, cellular and humoral components attribute to host 
defense. At the time of Behring’s description of antibodies, Paul Ehrlich published his “side-
chain-theory”. Therein he described cells that bear antigen-specific chains on their outer 
surface which can be shed on occasion and are able to bind pathogens, thereby providing the 
earliest description of what we now call B cells (EHRLICH 1897). Although at the beginning 
of the 20th century James B. Murphy established a role for small white blood cells termed 
lymphocytes in tissue and tumor graft rejection (MURPHY 1926), it was not before 1959 that 
James Gowan could focus the immunologists’ attention to these cells (SILVERSTEIN 2001). 
Soon thereafter B (bursal-derived) and T (thymus-derived) lymphocytes became the 
recognized elements in humoral and cellular immunity, respectively. A further breakthrough 
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in the understanding of adaptive immune responses was achieved by Robert L. Coffman and 
Timothy R. Mosmann in 1986 when they published the basis of our classical understanding 
of the dichotomy of T helper cell responses (MOSMANN et al. 1986). They described that 
the two branches of adaptive immunity, antibody-mediated and cell-mediated immunity, are 
governed by two different subsets of T lymphocytes, T helper type 1 (Th1) and T helper type 
2 (Th2) cells, which differ in their cytokine profile 
Cytokines form a group of proteins that act as intercellular communication signals. 
Produced by one cell, they affect the behavior of the cells bearing the appropriate receptor 
(JANEWAY et al. 2001). Their important role in coordinating the fine-tuned processes of 
immune defense put them in the center of immunological research since the 1980s and led to 
the development of novel treatment strategies. These strategies aim to enhance or suppress 
specific immune reactions by either administering or neutralizing cytokines. Understanding 
the role of cytokines will lead to understanding of the coordination of immune responses in 
host defense, and how failure of such protective mechanisms become manifest in 
autoimmune diseases and cancer.  
 
1.1 AIM OF STUDY 
Recently, a novel cytokine, interleukin (IL)-23, was discovered (OPPMANN et al. 2000) 
which is closely related to IL-12, a cytokine essential for protection in various models of 
intracellular infection (TRINCHIERI 2003). Meanwhile, an essential contribution of IL-23 in 
various models of autoimmune disease could be demonstrated (ALBER et al. 2006; 
MCKENZIE et al. 2006). This key role for IL-23 in chronic inflammation raised the question 
for its physiological role in host defense (HUNTER 2005; LANGRISH et al. 2004). 
Although there is evidence for a protective function of IL-23 in acute infections 
(MCKENZIE et al. 2006), its role in chronic infection could not yet be clearly defined.  
Due to its structural relationship to IL-12, first studies on the biological function of IL-23 
focused on the shared biological functions of both cytokines. The present work was 
performed in the light of the recently defined implication of IL-23 in a non-classical cellular 
immune response. The aim of the here presented study was (i) to define the role of this IL-23-
mediated immune pathway in a chronic infection model, murine cryptococcosis, and (ii) to 
unveil a possible mode of action for IL-23 in this context.  
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2 REVIEW OF LITERATURE 
 
2.1 CELLULAR IMMUNITY TO INFECTION 
2.1.1 Innate immunity: first line of defense 
Invading microorganisms are confronted immediately with a network of phagocytic cells, 
such as dendritic cells (DCs) and macrophages (mononuclear phagocytes) in tissues as well 
as polymorphonuclear phagocytes, such as neutrophils, and monocytes in the blood-stream.  
Macrophages are most important in initiating the local inflammatory response 
(JANEWAY et al. 2001). They mature continuously from circulating monocytes and reside 
in tissues. Conserved structures displayed on the pathogen surface, so-called pathogen-
associated molecular patterns (PAMPs), enable phagocytes to recognize and ingest the 
pathogens by specific pattern recognition receptors (PRRs) (KAISHO and AKIRA 2000). 
Not only internalization in a membrane-bounded vesicle known as phagosome with 
subsequent digestion of the pathogen is mediated by binding to PRRs, moreover, upon such 
stimulation macrophages and DCs release cytokines and chemoattractant proteins 
(chemokines) leading to local inflammation (JANEWAY et al. 2001). Important 
inflammatory cytokines produced by macrophages are IL-1β, IL-6 and tumor necrosis factor 
(TNF)-α. IL-1β and TNF-α induce activation of the vascular endothelium and increase 
vascular permeability; processes crucial for the infiltration of further leukocytes as well as 
increased drainage to lymph nodes. TNF-α is most important in the containment of infection; 
its neutralization leads to a systemic spread of otherwise local infections in mouse models. In 
addition, TNF-α stimulates DC migration to lymph nodes thus triggering the initiation of 
adaptive immunity (see below). IL-6 strongly induces the expression of hepatic acute-phase 
proteins. All three cytokines synergize in activating lymphocytes and, systemically, in 
inducing fever (JANEWAY et al. 2001).  
Chemokines produced by macrophages upon activation cause the influx of further 
inflammatory cells. Important such mediators are CXCL8 and monocyte chemoattractant 
protein 1 (MCP-1) with overlapping, but also distinct effects on cell recruitment (MUKAIDA 
et al. 1998). CXCL8 (or KC in mice) recruits a second major group of phagocytic cells from 
the blood to the site of infection, the neutrophils. They are short-lived cells that like 
macrophages internalize and destroy pathogens or produce microbicidal oxygen-derived 
products such as H2O2 in a process termed respiratory burst or toxic nitrogen oxides (NO). 
The production of MCP-1 leads to the influx of further macrophages as well as lymphoid 
cells, such as natural killer (NK) cells, another cell type of innate immunity. 
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NK cells bear invariant receptors; upon stimulation they release their cytotoxic granules onto 
the surface of the bound target. NK cells are activated in response to macrophage-derived 
cytokines such as IL-12, IL-18 and TNF-α. They are important in the early phase of infection 
with intracellular pathogens by means of cytotoxicity and interferon (IFN)−γ production 
(HAMERMAN et al. 2005). IFN-γ is a pleiotropic cytokine that plays an essential role in 
innate and adaptive immunity (SHTRICHMAN and SAMUEL 2001). Mutations of 
components in the IFN-γ signaling pathway are associated with strongly elevated 
susceptibility to infection mainly with intracellular pathogens (DORMAN and HOLLAND 
1998; JOUANGUY et al. 1996). Therefore, activated NK cells serve to contain infections 
with intracellular pathogens while adaptive immunity (also triggered by NK cell-derived 
IFN-γ) generates more specific means to clear the infection (see next section). 
The means of innate immunity described so far are efficient in repelling a broad range of 
microorganisms. Pathogens, however, have developed strategies to overcome such 
mechanisms. In these circumstances innate immunity paves the way for adaptive immune 
responses. DCs are most important in bridging innate and adaptive immunity as they, after 
antigen-uptake, migrate from tissues to the local lymph nodes where they initiate the specific 
immune response by priming naïve T cells which then become effector cells (JANEWAY et 
al. 2001). DCs, together with macrophages and B cells, function as antigen-presenting cells 
(APCs). They process phagocytized antigen and load the resulting peptides on major 
histocompatibility complex class 2 (MHC-II) molecules expressed on the surface thereby 
presenting it to T cells (RAMACHANDRA et al. 1999). Activation of APCs by microbial 
products up-regulates the expression of MHC molecules, thus enhancing their antigen-
presenting capacities. DC-primed T cells that migrate from lymph nodes to tissues are 
retained at the site of infection basically by MHC-presented antigen. In addition, APCs upon 
activation up-regulate co-stimulatory molecules that enhance the MHC-induced signal in T 
cells (COYLE and GUTIERREZ-RAMOS 2001). Macrophages and DCs are further the 
source of cytokines important for the induction and maintenance of adaptive cellular 
immunity. In this context the members of the IL-12 family of cytokines such as IL-12, IL-27 
and IL-23 (see chapter 2.2.1) as well as IL-18 play an important role (BROMBACHER et al. 
2003). 
Therefore, the two major tasks of innate immunity are the containment of infection or even 
rapid elimination of pathogens by macrophages, neutrophils and NK cells, as well as the 
initiation of adaptive immune response by macrophages and DCs. 
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2.1.2 Adaptive immunity: specificity and memory as strategies 
The central cells of adaptive immunity are T and B lymphocytes. Both, T and B lymphocytes 
respond to antigen presentation by specific recognition through their antigen receptors, the T 
cell and B cell receptor.  
T cells recognize peptide antigen only when it is presented on MHC-molecules. There are 
two classes of MHC molecules that are corresponding to two different T cell subsets. MHC 
class 1 (MHC-I) is expressed on almost every cell type and is recognized by cytotoxic T cells 
(CTL), expressing the cluster of differentiation (CD) antigen CD8 (co-receptor) on their 
surface. CTL are programmed to destroy their target cells. Upon recognition of altered or 
foreign antigen presented on MHC-I they release the cytotoxic granules onto the bound cell 
and induce cell death. While CD8+ T cells also express cytokines such as IFN-γ the most 
important producers of cytokines and thereby regulators of cellular immune responses are T 
helper (Th) cells, characterized by expression of co-stimulatory receptor CD4. Th cells 
recognize antigen presented on MHC-II molecules by their T cell receptor (TCR), hence they 
are only activated by APCs. 
TCR signaling is enhanced by co-stimulatory signals provided by APCs. The best 
characterized co-stimulatory molecules are the glycoproteins of the B7 complex, CD80 and 
CD86. Binding of APC-expressed B7 molecules to their common receptor CD28 on the T 
cell surface leads to the production of IL-2, most important for proliferation and clonal 
expansion of T cells and also activates NK cells. Conversely, inhibition of B7 molecule 
binding inhibits T cell responses (JANEWAY et al. 2001) demonstrating the importance of 
co-stimulatory signals provided by APCs.  
Upon TCR/CD28 signaling depending on the surrounding cytokine milieu naïve Th cells 
can commit to different lineages either promoting cell-mediated immunity (Th1) or 
enhancing B cell induced antibody-mediated immunity (Th2). 
The processes involved in Th1 commitment are still subject to extensive research. While 
IL-12 is shown to be essential for the Th1 maintenance, recently discovered cytokines such as 
IL-27 and IL-23 add to our understanding of the regulation of early and late-stage Th1 
responses. NK cell-derived early IFN-γ and APC-derived IL-27 initiate the Th1 program in 
naïve T ells in the context of TCR/CD28 activation characterized by expression of both 
IL-12R chains and consecutive production of IFN-γ (BROMBACHER et al. 2003). By 
activation via APC-derived IL-12 IFN-γ production is enhanced and the receptor for IL-18 is 
expressed on the cell surface. Signaling through functional IL-12 and IL-18 receptors on 
effector Th1 cells induces high-level IFN-γ production, the hallmark cytokine of the Th1 
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response (BROMBACHER et al. 2003). IFN-γ can activate microbicidal activity as well as 
cytokine production in macrophages; amongst others enhancing TNF-α-induced NO 
production (JANEWAY et al. 2001). IL-12 enhances their antigen presenting capacities 
(TRINCHIERI 2003). Moreover, IL-12 activates NK cells and induces IFN-γ production in 
such cells.  
A valuable tool in assessing Th1 responses is the delayed-type hypersensitivity (DTH) 
reaction, a local Th1 cell-mediated inflammatory response. The prototypic DTH response is 
an artifact of modern medicine - the tuberculin test. The mechanisms involved in the 
generation of a DTH response resemble the events of a regular effector Th1 response: Th1 
cells are retained at the site of antigen injection by MHC-II encountered antigen and produce 
cytokines such as TNF-α and IFN-γ as well as chemokines thereby inducing influx of 
macrophages and local inflammation.  
Collectively, Th1 responses lead to an enforcement of the cellular effector mechanisms of 
innate immunity thus making it a strong weapon in the struggle against intracellular 
pathogens. 
Th2 commitment in contrast is mediated by IL-4. Th2 cells are characterized by the 
production of IL-4 as well as IL-13, IL-5 and IL-10. Th2 responses are focused on the 
activation of B cells and the inhibition of macrophage activation. B cells bind and ingest 
antigen via their B cell receptor (membrane-bound immunoglobulin (Ig)) which leads to 
activation and the production of antigen-specific IgM antibodies. While this process is 
independent of T cells, the switch of Ig classes and the establishment of B cell memory are 
only possible when Th cells recognize MHC-II-bound antigen presented by B cells and in 
turn stimulate those B cells via CD40L/CD40 ligation. In case of Th2 cell/B cell interaction, 
subsequent IL-4 production leads to an Ig class switch to IgE, a hallmark Ig for Th2 
responses. Th2 responses are directed against extracellular pathogens that are accessible for 
antibodies. Conversely, antibody-mediated immunity is little effective against intracellular 
pathogens providing a rationale for the fact that Th2 responses are inhibited by the Th1 
pathway and vice versa.  
A most important feature of adaptive immunity is the establishment of immunological 
memory, the basic concept of vaccination. T memory cells can rapidly recall the Th1 or Th2 
cytokine pattern that was induced during primary stimulation. High-level cytokine secretion 
occurs within hours of secondary stimulation, TCR activation alone is sufficient to induce 
this robust recall response.  
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The outcome of inborn or acquired deficiencies of the adaptive immune system proves its 
importance. In horses, mainly Arabian horses, a mutant of the gene encoding the DNA-
dependent protein kinase leads to the absence of T and B cells in homozygous carriers. Those 
foals develop a severe combined immunodeficiency (SCID) and die of infections with 
opportunistic pathogens. In people the most frequent severe acquired immunodeficiency is 
AIDS caused by infection with the human immunodeficiency virus (HIV). The loss of CD4+ 
T cells in the devastating course of infection is hallmarked by secondary infections with 




2.2.1 Interleukin-23, a member of the IL-12 family of cytokines 
IL-23 is a recently discovered cytokine that possesses strong proinflammatory potential. 
Because of its close relationship to the prototypical Th1 cytokine IL-12 it is assigned to the 
IL-12 family cytokines (Fig. 1). The members of this cytokine family, including IL-23, are 
produced by activated APCs (D'ANDREA et al. 1992; OPPMANN et al. 2000; PFLANZ et 
al. 2002), whereas their receptors are expressed on broad range of myeloid and lymphoid 
cells (PARHAM et al. 2002; PRESKY et al. 1996). Microbial products are important stimuli 
for the expression of IL-12 family members by APCs which indicates their important role in 
immunity to infection (SCHUETZE et al. 2005; FEDELE et al. 2005; SMITS et al. 2004). 
IL-12 family cytokines are considered some of the most important soluble signals for 
induction of cellular immunity, acting at the interface of innate and adaptive immunity 
(BROMBACHER et al. 2003; LANGRISH et al. 2004; TRINCHIERI et al. 2003). The 
accurate interplay between these cytokines is an essential process in the orchestration of T 
cell responses. This implies that, to gain a better understanding of this crucial step in host 
defense, new findings concerning one cytokine of this family necessarily have to be put in 
context to the action of the others. Therefore, in the following, a brief introduction of the 
IL-12 family members will be given. Since the present work focused on exploring the role of 
IL-23 in host defense in a chronic infection model in which IL-12 has been shown to be an 
important player previously (DECKEN et al. 1998; KAWAKAMI et al. 1996), mainly the 
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2.2.1.1 IL-12 – an important player in the maintenance of Th1 responses 
In 1989 two different groups of scientists discovered IL-12 simultaneously and named it 
based on the observed biological activity NKSF (natural killer cell stimulatory factor) 
(KOBAYASHI et al. 1989) and CLMF (cytotoxic lymphocyte maturation factor) (STERN et 
al. 1990). Its first revealed immunological function was the induction of IFN-γ production in 
NK cells. Further research mainly in IL-12 deficient mice demonstrated an essential role for 
IL-12 in the induction (MAGRAM et al. 1996; MATTNER et al. 1996) and maintenance 
(PARK et al. 2000; YAP et al. 2000) of Th1 responses, which are especially required for 
protection against intracellular pathogens. IL-12 was the first cytokine to be found with a 
heterodimeric structure. It is composed of a 40 kDa subunit named p40 covalently linked to a 
35 kDa subunit p35 (KOBAYASHI et al. 1989; TRINCHIERI 2003). While the p35 subunit 
shares homology with other class I cytokines such as IL-6 and granulocyte-colony 
stimulating factor (G-CSF) (MERBERG et al. 1992) the p40 subunit, surprisingly, is 
homologous to the extracellular domain of the IL-6 receptor α chain (IL-6Rα) (GEARING 
and COSMAN 1991).  
 
2.2.1.2 (p40)2 – an antagonist of IL-12 with also proinflammatory potential 
Besides the production of IL-12 by activated macrophages and DCs a from 10 to 1000-fold 
excess production of the p40 subunit, but not the p35 subunit, was found (D'ANDREA et al. 
1992). Soluble p40 was shown to antagonize IL-12 bioactivity in vitro (MATTNER et al. 
1993) by binding to the IL-12 receptor (GILLESSEN et al. 1995), whereby the homodimeric 
form ((p40)2) showed higher bioactivity than the monomeric form of p40. In vivo, 
Fig. 1. IL-12 family of cytokines. 
Shown are the heterodimeric ligands 
IL-23, IL-12 and IL-27 as well as 
their two-chained receptors. 
Downstream signaling involves 
characteristic phosphorylation of 
signal transducer and activator of 
transcription (STAT) molecules. In 
addition to the depicted cytokines, 
the p40 subunit of IL-23 and IL-12 
is physiologically expressed in its 
monomeric as well as homodimeric 
form. Figure adapted from 
TRINCHIERI et al. (2003). 
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pretreatment with (p40)2 reduced LPS-induced circulating IFN-γ levels and protected mice 
from death (MATTNER et al. 1997). Moreover, mice genetically engineered to overexpress 
p40 in the liver developed impaired Th1 responses (YOSHIMOTO et al. 1998). In contrast, 
an agonistic function of (p40)2 is discussed but not yet defined in molecular terms. It could be 
shown that addition of (p40)2 to a mixed lymphocyte culture enhanced the induction of CD8+ 
T cells (PICCOTTI et al. 1997). Moreover, in Mycobacterium bovis BCG-infected mice 
double-deficient for IL-12p35 and p40 the administration of (p40)2 was able to restore the 
observed defect in antigen-specific DTH response (HOLSCHER et al. 2001).  
 
2.2.1.3 IL-23 – a proinflammatory cytokine structurally similar to IL-12 
In the year 2000 the novel cytokine IL-23 was identified by a computational database search 
for IL-6 related cytokines. IL-23 not only has a heterodimeric structure like IL-12, it even 
shares the p40 subunit with IL-12, which is in case of IL-23 covalently linked to a novel 
19 kDa subunit p19 (OPPMANN et al. 2000). Similar to the structural relationship of IL-23 
and IL-12, also their heterodimeric receptors are composed of a common chain termed IL-12 
receptor β1 (IL-12Rβ1) complemented by IL-23 receptor IL-23R for IL-23 (PARHAM et al. 
2002) and IL-12 receptor β2 for IL-12 (PRESKY et al. 1996) (Fig. 1). IL-23R as well as 
IL-12Rβ2 are crucial for transmembrane signaling by providing binding sites for signal 
transducer and activator of transcription (STAT) molecules. While IL-23 mainly activates 
STAT3 and STAT4 heterodimers, IL-12 signals via STAT4 (PARHAM et al. 2002). This 
difference, amongst others, accounts for the unexpected distinct effects of IL-23 as compared 
to IL-12 which will be discussed in the following sections. 
 
2.2.1.4 IL-27 – an initiator but also regulator of Th1 responses 
The IL-12 family member identified latest is termed IL-27, a heterodimer composed of 
Epstein-Barr Virus (EBV)-induced gene 3 (EBI3) and a novel 28 kDa polypeptide p28 
(Fig 1) (PFLANZ et al. 2002). While EBI3 shares homology with IL-12/IL-23p40, p28 is 
closely related to IL-12p35 and IL-23p19. Besides the ability of IL-27 to promote IFN-γ 
production in naïve but not memory T cells in vitro (PFLANZ et al. 2002) there is evidence 
that the specific IL-27 receptor chain WSX-1 (named after an amino acid motif in the 
intracellular domain) that associates with gp130 to form the functional IL-27R (PFLANZ et 
al. 2004) is essential for early initiation of Th1 responses in vivo (CHEN et al. 2000; 
YOSHIDA et al. 2001). In contrast, EBI3-deficient mice were resistant to Th2-mediated 
immunopathology associated with oxazolone-induced colitis (NIEUWENHUIS et al. 2002). 
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Recent studies point to an immunoregulatory function of IL-27 since WSX-1 deficient mice 
developed an immunopathological Th1 response in the course of Toxoplasma gondii 
(VILLARINO et al. 2003) and Trypanosoma cruzi (HAMANO et al. 2003) infection. Further 
studies in p28-deficinet mice will provide a clearer understanding of the biological function 
of IL-27 and its interplay with the other IL-12 family members. 
 
2.2.2 Immunological functions of IL-23 
2.2.2.1 IL-23 in adaptive immunity 
The IL-12 family of cytokines is commonly associated with Th1 promoting activities. 
Therefore, after discovery of IL-23 its effects on T cells were investigated first. In contrast to 
IL-12, IL-23 was able to induce IFN-γ production in memory cells but had no effect on naïve 
T cells (OPPMANN et al. 2000). Since IFN-γ is the hallmark cytokine of a Th1 response, this 
finding caused confusion about the contributions of IL-12 and IL-23 to Th1 commitment. 
However, mice specifically lacking IL-23 (IL-23p19-/- mice) displayed normal Th1 
development and IFN-γ production (MCKENZIE et al. 2006). In addition, the magnitude of 
DTH response in IL-23p19-/- mice immunized with methylated bovine serum albumin 
(mBSA) was comparable to WT mice at 18 hours post induction (GHILARDI et al. 2004). 
Interestingly, however, at later time points the DTH reaction was greatly diminished 
indicating a clear contribution of IL-23 in T cell functions (GHILARDI et al. 2004).  
Indeed, more recently, a more exclusive function could be contributed to IL-23: the 
promotion of IL-17 production in a certain T cell subset (AGGARWAL et al. 2003; 
LANGRISH et al. 2005). IL-17 is a potent inflammatory cytokine with effects on 
mononuclear as well as polymorphonuclear leukocytes (AGGARWAL and GURNEY 2002). 
It was identified about a decade ago and could be shown to be mainly produced by CD4+ T 
cells. IL-17 promotes inflammatory responses in primary and stable cell cultures and is 
elevated in rheumatoid arthritis, asthma, multiple sclerosis, psoriasis, and transplant rejection 
(KOLLS and LINDEN 2004). Mice specifically lacking IL-23 or IL-17 show an impaired 
antigen-specific cellular immune response (GHILARDI et al. 2004; NAKAE et al. 2002). 
More recently, IL-17 producing T cells were described as a T cell subset distinct from Th1 
and Th2 and termed Th17 (HARRINGTON et al. 2005; LANGRISH et al. 2005). 
Development of such cells was driven by IL-23 in vitro. Th17 cells besides IL-17 produced 
significant amounts of TNF-α and IL-6 but only little IFN-γ (LANGRISH et al. 2005). 
Moreover, IL-12 and/or IFN-γ appear to antagonize IL-23-induced IL-17 production in vitro 
(HARRINGTON et al. 2005; LANGRISH et al. 2005). Accordingly, in mice lacking IL-12 
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(IL-12p35-/- mice) IL-17 production is elevated as compared to WT mice (MURPHY et al. 
2003, unpublished observation). While a role for Th17 cells in promoting autoimmunity was 
shown (LANGRISH et al. 2005, see chapter 2.2.3) further work is required to characterize 
their physiological role. 
Little is known about the direct effects of IL-12 family cytokines on B cells. In IL-23p19-/- 
mice B cells seem to develop normally (GHILARDI et al. 2004). Consistently, IL-23p19-/- 
mice display normal levels of serum Igs and develop a normal T-cell-independent IgM 
response to trinitrophenol (TNP)-LPS or TNP-Ficoll (GHILARDI et al. 2004). T cell-
dependent antigens such as ovalbumin and type II collagen, however, induce impaired 
antibody responses (GHILARDI et al. 2004; MURPHY et al. 2003) suggesting a secondary 
effect of IL-23 on antibody-mediated immunity via CD4+ T cell help.  
 
2.2.2.2 IL-23 in innate immunity 
Though having important roles in bridging innate and adaptive immunity, IL-23 and IL-12 
also directly affect the cells of the innate immune system. IL-12 was shown to induce IFN-γ 
production in NK cells (TRINCHIERI 2003). In addition to the receptor for IL-12 human NK 
cells bear the IL-23R while a functional relevance has not been reported yet (PARHAM et al. 
2002.)  
The murine IL-23R is also expressed on cells that are the source of IL-23, macrophages 
and DCs, suggesting an autocrine or paracrine function for this cytokine (PARHAM et al. 
2002). Indeed, exogenous IL-23 enhanced IL-12 production in DCs. Moreover, IL-23-
pretreated peptide-pulsed DCs induced a stronger DTH response than mock-pretreated cells 
by a mechanism independent from IL-12 (BELLADONNA et al. 2002). Other indications for 
a role of IL-23 in innate immunity come from in vivo studies. Parallel to the multiorgan 
inflammation associated with elevated levels of serum TNF-α and IL-1β observed in mice 
genetically engineered to overexpress the p19 subunit of IL-23 (WIEKOWSKI et al. 2001), 
peritoneal macrophages produce TNF-α and IL-1β upon intraperitoneal injection of IL-23 
(CUA et al. 2003). These findings, however, do not necessarily reflect direct interaction of 
IL-23 with myeloid cells as it is possible that the expression of inflammatory cytokines is 
mediated by other IL-23-induced factors, such as IL-17. 
IL-23 effects on neutrophils are not sufficiently investigated yet. Neutrophils produced 
IL-17 in a model of LPS-induced airway neutrophilia (FERRETTI et al. 2003). While the 
authors pointed out IL-15 as a possible trigger, one might speculate about a role for IL-23. In 
a very recent report the IL-23/IL-17 axis was shown to be important for regulation of 
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granulopoiesis (STARK et al. 2005). Normal neutrophils migrate to tissues, where they 
become apoptotic and are phagocytized by macrophages and DCs. The authors show that this 
leads to phagocyte secretion of IL-23, which is controlling IL-17 production by T cells. IL-17 
then induced granulopoiesis via a G-CSF dependent mechanism. Antibody blockade of the 
p40 subunit of IL-23 could reduce neutrophil numbers in wild-type mice. Together these 
findings identified a role for IL-23 in homeostasis of neutrophil production in vivo. 
 
2.2.3 Biological and clinical relevance of IL-23 
2.2.3.1 IL-23 in host defense 
Despite its strong proinflammatory potential, a role for IL-23 in host defense has not yet been 
clearly defined. In acute Klebsiella pneumoniae infection IL-23-induced IL-17 is crucial for 
neutrophil recruitment to the infected airways and subsequent clearance of pathogen 
(HAPPEL et al. 2005a; YE et al. 2001a). In an acute model of Toxoplasma gondii infection 
IL-17R-/- mice show a higher mortality associated with impaired neutrophil recruitment to the 
infected sites (KELLY et al. 2005), whereas in another model of acute toxoplasmosis 
IL-23p19-/- mice were as resistant as wild-type mice (LIEBERMAN et al. 2004).  
Attempts to address the role of IL-23 in host defense during chronic infection have raised 
many questions. In a very recent report on M. tuberculosis infection, IL-23 was dispensable 
for protection, although it was crucial for the promotion of antigen specific IL-17 (KHADER 
et al. 2005). However, the authors showed that in the absence of IL-12, IL-23 provides a 
moderate level of protection. This observation parallels previous reports which showed, that 
mice lacking the p40 subunit of IL-12/IL-23 are more susceptible to chronic infection with 
intracellular pathogens than mice lacking the p35 subunit of IL-12 (COOPER et al. 2002; 
DECKEN et al. 1998; ELKINS et al. 2002; HOLSCHER et al. 2001; LEHMANN et al. 
2001; LIEBERMAN et al. 2004). In the murine model of infection with C. neoformans it was 
shown that IL-12p35-/- and p40-deficient mice both develop a Th2 response associated with 
elevated susceptibility (DECKEN et al. 1998). This pointed to the essential role of IL-12 in 
immunity to C. neoformans. Nevertheless, IL-12p35-/- mice still were able to form 
granulomata when infected with C. neoformans, whereas granuloma formation in mice 
lacking the p40 subunit was greatly impaired (DECKEN et al. 1998). From these data the 
authors concluded that another p40-dependent factor may contribute to the protective cellular 
immunity to C. neoformans infection. Today’s knowledge of IL-23 and the availability of 
IL-23p19-/- mice allow for assessing the particular role of IL-23 in chronic granulomatous 
inflammation induced by C. neoformans infection, as herein presented. 
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2.2.3.2 IL-23 in cancer 
A physiological role of IL-23 in preventing transformation of cells has not yet been 
investigated. Documented studies so far focused on assessing antitumor activity of IL-23 in 
tumor cells engineered to express this cytokine, either by viral transduction or gene-gun 
therapy. In models of colon carcinoma and melanoma cells, retroviral transduction of tumor 
cells revealed potent antitumor activities for IL-23 that were mediated by CTL (LO et al. 
2003). In a further study, combined gene-gun therapy with IL-23 and IL-18 resulted in a 
significant suppression of implanted melanomas similar to combined IL-12/IL-18 therapy 
(WANG et al. 2004). While IL-12/IL-18 therapy strongly induced IFN-γ, IL-23/IL-18 
treatment only moderately enhanced IFN-γ production in stimulated splenocytes. 
Interestingly, both treatment regimens led to comparable CTL-mediated killing activity 
(WANG et al. 2004). Taken together, IL-23 gene-therapy-mediated antitumor activity seems 
to rely on an IFN-γ-independent enhancement of cell-mediated killing. 
 
2.2.3.3 IL-23 in autoimmunity 
In the past many studies investigating the mechanisms of autoimmune inflammation focused 
on describing a role for the IL-12/IFN-γ axis and were performed either in p40-deficient mice 
or with p40-neutralizing antibodies. In both cases IL-12 as well as IL-23 functions were 
inhibited. Meanwhile, in two models of chronic T cell-mediated autoimmune inflammation, 
experimental autoimmune encephalomyelitis (EAE) (CUA et al. 2003) and collagen-induced 
arthritis (CIA) (MURPHY et al. 2003), IL-23 rather than IL-12 was shown to be the critical 
cytokine in the development of chronic inflammation. EAE serves as a model for human 
multiple sclerosis, whereas CIA is an accepted model for rheumatoid arthritis. In both studies 
mice specifically lacking IL-23 (IL-23p19-/- mice (OPPMANN et al. 2000)) were completely 
resistant to disease. Conversely, in EAE, transfer of in vitro generated antigen- and IL-23-
driven IL-17-producing T cells was decisive for disease onset in naïve mice (LANGRISH et 
al. 2005). There are indications in the recent literature that IL-23 might also be involved in 
the pathogenesis of other T cell-mediated autoimmune diseases such as psoriasis vulgaris, 
inflammatory bowel disease and type I diabetes (MCKENZIE et al. 2006). Collectively, 
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2.3 CRYPTOCOCCOSIS 
2.3.1 Cryptococcus neoformans – causative agent of cryptococcosis 
Cryptococcus neoformans is an encapsulated yeast (Fig. 2) and was first isolated from a tibia 





Class:  Heterobasidiomycetes 
Subclass: Tremellomycetidae 
Order:  Filobasidiales 
Genus:  Cryptococcus 
 
Fig. 2: Morphology and taxonomical classification of Cryptococcus neoformans spp. 
C. neoformans cells are round to oval; budding yeasts measure 4-6 μm. The cells are 
encountered by a polysaccharide capsule with a diameter of 1 to >30 μm (CASADEVALL 
and PERFECT 1998). Figure adapted from BUCHANAN and MURPHY (1998).  
 
The genus Cryptococcus (for taxonomic classification see Fig. 2) includes around 37 species. 
Among these, C. neoformans is the only species that is facultative pathogenic. C. neoformans 
was generally accepted to include three varieties, var. gattii, var. grubii and var. neoformans 
(LEVITZ 1991; FRANZOT et al. 1999). Differences between the three varieties with regard 
to pathogenicity and geographical distribution have been described. C. neoformans var. 
neoformans and var. grubii are responsible for most cases of cryptococcosis in 
immunocompromised patients, and C. neoformans var. gattii has been associated with 
infections in subjects with a normal immunologic status (ELLIS 1987; SPEED and DUNT 
1995). C. neoformans var. neoformans and var. grubii have a worldwide distribution 
(BENNETT et al. 1977), whereas C. neoformans var. gattii has been reported to be mainly 
restricted to tropical and subtropical areas (BARO et al. 1999). 
 
2.3.2 Pathogenesis of C. neoformans infection and host defense 
The infection process by C. neoformans commonly starts following inhalation of the yeasts 
into the lung (MITCHELL and PERFECT 1995). Infecting fungal cells are initially 
confronted by alveolar macrophages as well as DCs, and subsequently by T cells, 
macrophages, granulocytes, and natural killer cells. If the host is immunocompromised, 
C. neoformans yeasts escape from host defense using various pathogenic mechanisms. The 
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polysaccharide capsule and phenol oxidase enzyme of Cryptococcus neoformans, as well as 
its ability to grow at 37°C, are its major virulence factors (MITCHELL and PERFECT 1995). 
Phenol oxidase enzyme functions in production of melanin. The melanizing enzyme 
presumably prevents formation of toxic hydroxy radicals and thus protects the fungal cell 
from oxidative stress as well as the immune defense mechanisms of the host 
(CASADEVALL et al. 2000; JACOBSON 2000). C. neoformans can then disseminate in 
other tissues especially the brain, causing lethal meningoencephalitis (MITCHELL and 
PERFECT 1995). The importance of the capsule shows in experiments with acapsular mutant 
strains, which are non-virulent in mouse models of cryptococcosis (FROMTLING et al. 
1982). Glucuronoxylomannan (GXM), the major capsular polysaccharide of C. neoformans is 
antiphagocytic, blocks both recruitment of inflammatory cells and the increase in 
costimulatory molecules (BREEN et al. 1982; KOZEL and MASTROIANNI 1976). GXM 
was found to suppress DTH and may reduce antibody production in response to fungal 
infection (BLACKSTOCK and CASADEVALL 1997; BREEN et al. 1982). The mentioned 
characteristics of C. neoformans are crucial for the yeasts survival in the host, yet they are 
complemented by other virulence factors that will not be further discussed here. 
Although C. neoformans was originally recognized as an extracellular pathogen, in vitro 
and in vivo studies accumulated evidence for its intracellular parasitism within macrophages 
(FELDMESSER et al. 2001). This facultative intracellular parasitism of C. neoformans 
accounts to the fact, that the host’s antibody response is not very effective against this 
pathogen (MITCHELL and PERFECT 1995). In contrast, cell-mediated immunity is essential 
for eradicating C. neoformans as shown by the severe exacerbation of disease in mice lacking 
essential components of the Th1 pathway, such as CD4+ T cells, IFN-γ or IL-12 (CHEN et al. 
2005; DECKEN et al. 1998; HILL and HARMSEN 1991). 
 
2.3.3 Clinical manifestation in humans and domestic mammals 
Given the neurotropic nature of the fungus, the most common clinical form of cryptococcosis 
in humans and small companion animals is meningoencephalitis (MITCHELL and PERFECT 
1995). The course of the infection is usually subacute or chronic.  
The most commonly encountered predisposing factor for development of cryptococcosis in 
humans is AIDS (MITCHELL and PERFECT 1995). Cryptococcosis presents the most 
common fungal infection of the brain in AIDS patients in the USA and is the fourth leading 
cause of death. Less commonly, organ transplant recipients or cancer patients receiving 
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chemotherapeutics or long-term corticosteroid treatment may develop cryptococcosis 
(KORFEL et al. 1998; URBINI et al. 2000).  
Although cryptococcosis is dramatically potentiated in humans by concomitant infection 
with HIV, disseminated cryptococcosis is not strongly associated with cats that are infected 
with FIV. Still, C. neoformans infection presents one of the most common systemic fungal 
diseases in cats and dogs and is associated with respiratory and central nervous symptoms 
(HORMANSDORFER and BAUER 2000). In horses cryptococcosis presents as a rhinitis or 
sinusitis whereas in cattle mastitis caused by C. neoformans is seen on occasion. Pigeons and 
other birds are resistant, most likely because of their high body temperature and are 
considered the most important reservoir of C. neoformans.  
 
2.3.5 Experimental C. neoformans infection 
Most strains of mice are highly susceptible to experimental infection with a small number of 
yeasts (MITCHELL and PERFECT 1995). The availability of diverse inbred mouse strains 
and the variety of mice with targeted gene disruptions thereby pave the way for extensive 
studies on immunity against C. neoformans infection to provide more effective treatment 
options for cryptococcosis itself. On the other hand, however, experimental cryptococcosis 
displays a valuable tool in investigating the orchestration of cell-mediated immunity in 
general since this branch of the immune system has been proven to be essential for host 
defense in cryptococcosis. 
 
2.4 EXPERIMENTAL APPROACH OF PRESENT STUDY 
The importance of cell-mediated immunity in C. neoformans infection is the cause for the 
elevated susceptibility to infection observed in mice lacking the p35 or the p40 subunit of 
IL-12 (DECKEN et al. 1998). Although both genotypes develop a sustained Th2 response, 
p40-deficient mice are more susceptible to infection than IL-12p35-/-, pointing to a 
contribution of a p40-dependent but Th1-independent host defense mechanism (DECKEN et 
al. 1998). The present study seeks to identify the means of this non-classical immune 
pathway and define the role of IL-23 in its regulation.  
In a first step of the present work the question, if IL-23 accounts for the observed 
difference between the two IL-12 deficient mouse strains was addressed by administration of 
IL-23 to p40-deficient mice. 
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In a second series of in vivo studies the particular role of IL-23 in protection to 
C. neoformans infection was investigated by infection of IL-23p19-/- mice with a main focus 
on the cellular immune response and the IL-23-induced cytokine profile. 
The third set of experiments focused on further defining the means of IL-23 actions. By 
administration of recombinant IL-23 to wild-type (WT) mice as well as mice deficient for 
genes encoding for factors important for adaptive immunity, the effects of IL-23 on the 
adaptive and innate immune system were assessed. The main focus herein was the cellular 
composition of inflammatory infiltrates to the site of infection and the local cytokine 
expression. 
The last part of the present work describes a protein purification process of homodimeric 
p40 from insect cell culture supernatants. This work was performed as a basis for further 
investigations of the interplay between IL-23 and other IL-12 family members in the course 
of infection. 
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3 ANIMALS, MATERIALS AND METHODS 
 
3.1 MICE 
Wild-type, IL-12p35-/- and p35/40-/- (MAGRAM et al. 1996; MATTNER et al. 1996) mice 
on a C57BL/6 background were bred and maintained in individually ventilated caging units 
(Ehret, Berlin, Germany) under specific pathogen-free conditions within the animal facility at 
the Institute of Immunology, Faculty of Veterinary Medicine, University of Leipzig and in 
accordance with the guidelines approved by the Animal Care and Usage Committee of the 
Regierungspräsidium Leipzig, Germany (record numbers 24-916811-5/01 and 24-9168.11-
36/04). WT, RAG2-/-, IL-12p35-/-, p40-/- (MAGRAM et al. 1996; MATTNER et al. 1996) and 
IL-23p19-/- (CUA et al. 2003) mice on a C57BL/6 background were also maintained at 
DNAX Research Institute (Palo Alto, CA, USA). RAG1-/- mice on a C57BL/6 background 
were obtained from the Jackson Laboratory, Bar Harbor, Maine, USA. All animal procedures 
were approved by the DNAX Institutional Animal Care and Use Committee, in accordance 
with AAALAC (Association for Assessment and Accreditation of Laboratory Animal Care 
International) guidelines. Female mice were used at 8-12 weeks of age. As p35/40-/- and p40-/- 
mice showed no differences in the parameters of infection and immunity that were 




ELISA and multiplex array equipment: 
ELISA-Reader: Spectra-max 340 Molecular Devices, Munich, Germany  
ELISA-Washer (Ultrawash PLUS) DYNEX Technologies, Chantilly, VA, USA 
Immunoplates Maxisorb NUNC, Wiesbaden, Germany 
LUMINEX 100TM  LUMINEX corp., Austin, TX, USA 
Flow cytometry equipment: 
FACS Calibur Becton Dickinson, Franklin Lakes, NJ, USA 
Microscopes: 
Axiovert 25 Carl-Zeiss, Jena, Germany 
Axioskop 2 plus Carl-Zeiss, Jena, Germany 
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Cell culture equipment: 
CO2-incubator for cell culture Heraeus, Osterode, Germany 
Incubator for fungal growth  Memmert, Schwabach, Germany 
Cell culture plates Becton Dickinson, Franklin Lakes, NJ, USA 
Cell strainer Becton Dickinson, Franklin Lakes, NJ, USA 
Centrifuges: 
Megafuge 2.0 R Heraeus, Osterode, Germany 
Multifuge3 S-R Heraeus, Osterode, Germany 
Centrifuge 5417C Eppendorf, Hamburg, Germany 
Gel electrophoresis and Western Blotting equipment: 
Electrophoreses chamber Bio-Rad Laboratories, Hercules, CA, USA 
Power supply model 200/2.0 Bio-Rad Laboratories, Hercules, CA, USA 
Scopix LR 5200 imager AGFA, Morstel, Belgium 
Chromatography system: 
AKTAPrime Amersham Biosciences, Buckinghamshire, UK 
HiPrep CM Sepharose FF column Amersham Biosciences, Buckinghamshire, UK 
Scales: 
Mettler PM 4000 Mettler Toledo GmbH, Giessen, Germany 
Mettler AB184-S-A Mettler Toledo GmbH, Giessen, Germany 
Miscellaneous: 
pH meter inoLab® Level2 WTW GmbH, Weilheim, Germany 
Benchtop incubator GFL 3031 Ges. f. Labortechnik mbH, Burgwedel, Germany 
Laminar flow hoods: HERA-safe Heraeus, Osterode, Germany 
Ultra-Turrax homogenizer Ika-Werke GmbH, Staufen, Germany 
Waterbath: Isotemp 205 Scientific Support, Hayward, CA, USA 
Pipettes and pipettors Eppendorf, Hamburg, Germany 
Mouse restrainer Braintree Scientific, Braintree, MA, USA 
Vacuum manifold Millipore, Billerica, MA, USA 
Consumables: 
Test tubes, syringes, needles Becton Dickinson, Franklin Lakes, NJ, USA 
Pipette tips Eppendorf, Hamburg, Germany 
Serum separator Becton Dickinson, Franklin Lakes, NJ, USA  
 
3.2.2 Software 
LUMINEX software LUMINEX corp., Austin, TX, USA 
 Acquisition of multiplexing bead array data by 
 LUMINEX100 instrument 
Masterplex QT MiraiBio, Alameda, CA, USA 
 Analysis of LUMINEX data 
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Softmax Pro 3.1.2 Molecular Devices, Sunnyvale, CA, USA 
 Acquisition and analysis of ELISA-Reader data 
BD CellQuest™ pro Becton Dickinson, Franklin Lakes, NJ, USA 
 Acquisition and analysis of flow cytometry data 
GraphPad Prism™ 4 GraphPad Software, San Diego, CA, USA 
Statistics and data visualization 
Reference Manager Pro 11 Thomson Research Soft, Carlsbad, CA, USA  
 Management of bibliographies 
Adobe Photoshop CS Adobe Systems inc., San Jose, CA, USA 
 Digital imaging 
Excel® XP Microsoft, Redmond, WA, USA 
 Spreadsheet analysis 




3.2.3.1 Natural products 
Fetal calf serum (FCS) PAA Laboratories, Coelbe, Germany  
Gelatine (porcine) Merck, Darmstadt, Germany 
Glucose Sigma-Aldrich, Taufkirchen, Germany 
Penicillin/Streptomycin (104 U/ml, 10 mg/ml) Sigma-Aldrich, Taufkirchen, Germany 
Tryptone Roth GmbH, Karlsruhe, Germany 
LPS (from Salmonella abortus equi, S-Form)  Alexis, Grünberg, Germany 
Nitratereductase Roche, Nutley, NJ, USA 
NADPH Roche, Nutley, NJ, USA 
(Nicotinamide adenine dinucleotide hydrophosphated) 
 
3.2.3.2 Chemical reagents 
2,2’-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) 
(ABTS) Sigma-Aldrich, Taufkirchen, Germany 
Acrylamide Roth GmbH, Karlsruhe, Germany 
Agar-Agar Roth GmbH, Karlsruhe, Germany 
Ammonium peroxodisulfate (APS)  Merck, Darmstadt, Germany 
Bromphenol blue Sigma-Aldrich, Taufkirchen, Germany 
EDTA (sodium salt) Merck, Darmstadt, Germany 
Ethanol (analytical grade) Appli Chem, Darmstadt, Germany 
Formaldehyde (37 vol %) Roth GmbH, Karlsruhe, Germany 
Isoflurane Baxter, Munich, Germany 
Isopentane Fluka, Neu-Ulm, Germay 
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Naphtylethylendiamide-dihydrochloride Sigma-Aldrich, Taufkirchen, Germany 
N, N, N’, N’-tetramethylethylendiamine  Sigma-Aldrich, Taufkirchen, Germany 
(TEMED)  
Polyoxyethylene sorbitan-monolaurate  Roth GmbH, Karlsruhe, Germany 
(Tween 20)  
Sodium dodecylsulfate (SDS) Sigma-Aldrich, Taufkirchen, Germany 
Sulfanylamide Sigma-Aldrich, Taufkirchen, Germany 
Trypan blue Sigma-Aldrich, Taufkirchen, Germany 
 
All other chemicals were analytical grade and obtained from Roth, Sigma-Aldrich or Merck. 
Only high purity solvents were used for ÄKTAPrime gelfiltration runs.  
 
3.2.4 Biological material 
3.2.4.1 Cryptococcus neoformans 
The encapsulated highly virulent C. neoformans strain 1841, serotype D, was obtained from 
F. Hoffmann-La Roche Ltd, Basel, Switzerland (originally isolated from an AIDS patient) 
and kept as frozen stock in 10% skim milk at -20°C (DECKEN et al. 1998). The acapsular 
C. neoformans serotype D strain CAP67 was kindly provided by Dr. Bettina Fries, Albert-
Einstein College of Medicine, Bronx, NY, and maintained in the same conditions as strain 
1841.  
 
3.2.4.2 Cytokines and antibodies 
3.2.4.2.1 Antibodies and protein standard for ELISA 
 
Analyte Capture Ab Detection Ab Protein std. Source 
IgE R35-72 R35-118 (biot.) rmIgE C38-2* BD Pharmingen 
murine 
p40 
5C3 Polyclonal goat anti 
mouse p40 (biot.) 
CHO derived 
murine (p40)2 
provided by M. Gately, F. 
Hoffmann-La Roche Ltd, 
Nutley, NJ, USA 
IFN-γ AN-18 XMG (peroxidase-
labeled) 
rmIFN-γ∗ F. Hoffmann-La Roche 
Ltd, Basel, Switzerland 
 
 Table 1: Antibodies and protein standards for ELISA. *, rm = recombinant murine. 
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3.2.4.2.2 Antibodies for flow cytometry  
 
















dendritic cells CD11c Allophycocyanin hamster IgG1 
granulocytes Gr1 PE rat IgG2b 
 
Table 2. Antibodies for flow cytometry. Unspecific binding was prevented by blocking 
Fcγ III/II receptors with purified anti-mouse CD16/CD32. For intracellular cytokine staining 
IFN-γ-Allophycocyanin (rat IgG1) was used. All antibodies and isotype controls were 
purchased from BD Pharmingen, Franklin Lakes, NJ, USA. 
 
3.2.4.2.3 Cytokines for in vivo treatment 
rmIL-23 was expressed and purified at DNAX Research, Palo Alto, CA; USA (OPPMANN 
et al. 2000) and provided as a kind gift by Dr. Robert A. Kastelein; rmIL-12 and 
homodimeric p40 ((p40)2) were expressed and purified at Hoffmann-La Roche (Roche), 
Nutley, NJ (GATELY et al. 1996) and provided as a kind gift by Dr. Maurice Gately. For in 
vivo treatment, cytokines were diluted in PBS containing 1% genotype-specific mouse 
normal serum. 
 
3.2.5 Media for murine and fungal cell culture 
RPMI medium (for splenocyte cultures) 
 RPMI 1640  1x medium containing glutamine (Mediatech, Herndon, VA, USA) 
 10 % (v/v)  fetal calf serum (FCS) 
 1 % (v/v) Penicillin/Streptomycin (104 U/ml, 10 mg/ml) 
Sabouraud medium (for growth of C. neoformans) 
 2% glucose (w/v) 
 1% peptone  in ddH2O 
Sabouraud solid medium (for growth of C. neoformans) 
 1% Agar Agar in Sabouraud medium 
Cryomedium for C. neoformans stock 
 10 % (w/v) skim milk  in PBS 
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3.2.6 Buffers and solutions 
3.2.6.1 Buffers and solutions for cell culture 
PBS 
 0.80 % (w/v) NaCl 
 0.02 % (w/v) KCl 
 0.23 % (w/v) Na2HPO4 × 2 H2O 
 0.02 % (w/v) KH2PO4  pH = 7.4 in double distilled water (ddH2O) 
PBS/FCS 
 3% FCS (v/v) in PBS 
Trypan blue 
0.9 % (w/v) NaCl 
0.4 % (w/v) trypan blue 
 
3.2.6.3 Buffers and solutions for ELISA 
10x PBS 
 0.35 % (w/v)  KH2PO44 
 1.58 % (w/v)   Na2HPO4 
 8.50 % (w/v)   NaCl 
Carbonate-buffer 
 1.73 % (w/v) NaHCO3  
 0.86 % (w/v)  Na2CO3  pH = 9.5 
Blocking buffer 
 0.1 % (w/v) gelatine (porcine) 
 0.5 % (w/v) BSA    in 1x PBS 
Serum diluent 
 0.10 % (w/v) gelatine (porcine) 
 0.05 % (v/v) Tween 20  in 1x PBS 
Washing buffer 
0.05 % (v/v) Tween 20   in 1x PBS 
Substrate-buffer 
 10 ml McILVAIN´s buffer (96.3 mM Na2HPO4, 53.2 mM citric acid) 
10 mg ABTS 
10 µl H2O2 to 10 ml McILVAIN´s buffer 
 
3.2.6.4 Buffers and solutions for nitric oxide determination 
Griess reagent 
  Sol. A:     0.1 % (w/v) naphtyethylendiamide-dihydrochloride 
 Sol. B:     1.0 % (w/v) sulphanilamide in 5 % concentrated H3PO4 
 Working solution: 1:1 dilution of solution A and B (stable for 12 hrs) 
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3.2.6.5 Buffers and solutions for SDS-PAGE 
Separating gel (10 ml):  
 3.34 ml 30% acrylamide-bisacrylamide (37:1)  
 2.5 ml 1.5 M Tris/HCl (pH 8.8) 
 4 ml ddH2O  
 100 μl 10% (w/v) SDS  
 5 μl TEMED (N, N, N’, N’-tetramethylethylendiamine) 
 50 μl 10% (w/v) APS (ammonium peroxodisulfate)  
Stacking gel (5 ml):  
 1.5 ml 30% acrylamide-bisacrylamide (37:1)  
 2.5 ml 0.5 M Tris/HCl pH 6.8  
 5.5 ml ddH2O  
 100 μl 10% (w/v) SDS  
 30 μl TEMED  
 30 μl 10% (w/v) APS  
Running buffer:  
 50 mM Tris 
 192 mM glycine 
 0.1 % (w/v) SDS in ddH2O 
Sample buffer (2x)  
 60 % glycerol  
 0.5 M Tris/HCl pH 6.8  
 10% (w/v) SDS  
 0.05% (w/v) bromphenol blue  
 
3.2.6.6 Buffers and solutions for Western blot assays 
Blotting buffer (pH 9.2) 
 48 mM Tris/HCl pH 9.2  
 39 mM glycine  
 1.3 mM SDS  
 20% (v/v) Methanol 
TBS buffer (pH 7.5) 
 20 mM Tris/HCl pH 7.6  
 137 mM sodium chloride  
TBS-T buffer (pH 7.5) 
 TBS Buffer (pH 7.5) 
 0.1 % Tween 20  
Blocking solution 
TBS-T buffer containing 3% (w/v) gelatine 
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3.2.6.7 Buffers and solutions for liquid chromatography 
Phosphate buffer 20mM pH 7.2 (with and without NaCl) 
0.2 M monobasic stock 
13.9 g sodium phosphate monobasic 
500 ml dH20 
 
0.2 M dibasic stock 
53.65 g sodium phosphate dibasic heptahydrate 
1 L dH20 
 
0.1 M buffer pH 7.2 
600 ml dH2O 
84 ml monobasic stock 
216 ml dibasic stock 
  
20 mM sodium phosphate buffer pH 7.2 
dilute 0.1 M buffer 1:5 in dH2O 
 
 20 mM sodium phosphate buffer pH 7.2 0.5 M NaCl 
 add 0.5 mol NaCl to 1 L of 20 mM sodium phosphate buffer pH 7.2 for salt gradient 
 
3.2.6.2 Buffers and solutions for flow cytometry 
FACS buffer (washing and dilution buffer) 
3.0 % (v/v) FCS  
0.1 % (w/v) NaN3   in 1x PBS 
Fixation buffer 
1.48 % (v/v) formaldehyde in 1x PBS 
 
3.2.7 Kits and ready-made solutions 
Cell culture: 
0.02% EDTA solution in DPBS Sigma-Aldrich, Taufkirchen, Germany 
RBC lysis buffer Sigma-Aldrich, Taufkirchen, Germany 
Protein purification: 
SilverQuest Invitrogen, Carlsbad, CA, USA 
BCA Protein Assay Kit Pierce Biotechnology, Rockford, IL, USA 
LUMINEX assay reagents: 
Beadlyte Mouse Multi-Cytokine 
Detection System 2 Upstate Biotech., Lake Placid, NY, USA 
Additional IL-17 and MCP-1 bead sets Upstate Biotech., Lake Placid, NY, USA 
Histology: 
ornithine carbamyl transferase (O.C.T.) 
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embedding medium Miles Scientific, Naperville, IL, USA 
Vectastain® Elite® ABC-Kit  Vector Laboratories, Burlingame, CA, USA 
mRNA analysis: 
RNA STAT-60TM  Iso-Tex Diagn., Friendswood, TX, USA 
RNeasy® Qiagen, Valencia, CA, USA 
 
3.3 METHODS 
3.3.1 In vivo procedures 
3.3.1.1 Infection of mice and monitoring of survival 
C. neoformans strain 1841 was cultured in Sabouraud dextrose medium (2% glucose, 1% 
peptone) in cultures grown overnight at 30°C. Cells were washed twice with sterile PBS and 
counted in a hematocytometer. Inocula were resuspended in sterile phosphate-buffered saline. 
Since it was reported previously that injection of 10,000 CFU of C. neoformans strain 1841 
results in a chronic, eventually lethal infection in C57BL/6 mice (DECKEN et al. 1998), this 
inoculum was used in the present study to assess long-term T cell functions. Therefore, mice 
were infected with 10,000 CFU of C. neoformans strain 1841 resuspended in either 500 µl 
PBS for intraperitoneal (i.p.) injection or in 100 µl PBS for intravenous (i.v.) application. 
Both, i.p. and i.v. infection resulted in the development of chronic infection with a similar 
course of infection (survival period, organ burden). 
Infected mice were monitored daily for morbidity and mortality. In accordance to animal 
welfare guidelines mice were euthanized when moribund. 
 
3.3.1.2 Cytokine injections 
Recombinant murine IL-23 (rmIL-23) was expressed and purified at DNAX Research, Palo 
Alto, CA, USA (OPPMANN et al. 2000) and provided as a kind gift by Dr. Robert A. 
Kastelein. For reconstitution of p40-deficient mice rmIL-23 (2 µg per injection) or PBS 
containing 1% of genotype specific mouse normal serum was administered i.p. beginning two 
days before infection, continued daily until day 20 post infection (p.i.) and twice a week 
thereafter. WT mice were treated with either rmIL-23 (2 µg per injection) or rmIL-12 (kindly 
provided by Dr. M. Gately, Hoffmann-La Roche, Nutley, NJ) (0.1 µg per injection) or PBS 
containing 1% of genotype specific mouse normal serum in the same manner. In experiments 
with an end point at day 8 p.i., p40-deficient, RAG1-/- and RAG2-/- mice were treated with 
rmIL-23 (2 µg per injection) or PBS intraperitoneally starting two days before infection and 
continued daily until day 7 p.i. All cytokine injection solutions were prepared with sterile 
PBS containing 1% mouse normal serum; PBS for control group injections also contained 1% 
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At days 21, 35, and 49 p.i. tail vein blood was obtained from WT and IL-23p19-/- mice to 
assess the immunological status in the serum. Therefore, mice were put in a mouse restrainer 
and the lateral tail vein was incised with a razor blade. The dripping blood was collected in 
serum separator tubes, centrifuged at 7,000 g for 5 min and stored at -80°C until further 
analysis. 
 
3.3.3 Dissection of mice 
3.3.3.1 Time points of dissection 
Since the present study focused mainly on the cellular immune response, in a series of 
preparative experiments and time course analyses the optimal time points to assess organ 
specific inflammation in this model of C. neoformans infection were determined (data not 
shown). Four time points of interest were identified: The inflammatory response in the liver 
peaked at day 21 p.i.; at day 35 and 49 p.i. a pronounced inflammatory response in the brain 
was observed. The processes at the site of infection were assessed at day 8 p.i. as cytokine 
treatment showed effective at this time point. The specific days of section are indicated in the 
results section. 
 
3.3.3.2 Experimental procedure 
Dissections were performed under sterile conditions in a laminar flow hood. Mice were 
anesthetized with CO2 according to animal welfare guidelines and fixed on styrofoam-boards. 
After superficial disinfection the ventral skin was opened in the median by a caudocranial 
incision from the pelvis to the neck. Following cardiac puncture and peritoneal lavage (PEL), 
if applicable, organs were removed. In experiments where brain samples were taken for 
immunohistochemical analysis mice were perfused intracardially through the left ventricle 
with 0.9 % saline under deep isoflurane anesthesia before organ removal. 
 
3.3.3.2.1 Cardiac puncture 
Following CO2 anesthesia blood was collected via cardiac puncture. With a 23 gauge needle 
attached to a 1 ml syringe the right ventricle was punctured by inserting the needle cranial of 
the xiphoid cartilage into the unopened thorax. The blood was transferred into serum 
separator tubes, centrifuged at 7,000 g for 5 min and stored at -80°C until further analysis. 
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3.3.3.2.2 Peritoneal lavage 
2 ml of ice-cold PBS/EDTA were instilled into the abdomen through a 23 gauge needle 
inserted in the inguinal region. Peritoneal lavage fluid was recovered by insertion of the 
needle through the cranial peritoneum. This first PEL fluid was taken for fungal burden 
determination as well as cytokine and chemokine assessment. A second lavage with a volume 
of 5 ml PBS/EDTA was performed as described above and pooled with the cells of the first 
lavage to obtain enough cells for flow cytometry analysis.  
 
3.3.3.2.3 Organ removal 
The peritoneal cavity was opened by a median cut from the pelvis to the xiphoid cartilage. 
Liver and spleen were removed. Then, the skin was opened by a median incision at the back 
of head and neck. Through the foramen magnum scissors were inserted into the cranial 
cavity, and after removal of the skullcap the brain was taken out. Organs were weighed and 
dissected in sterile petri dishes for further processing. 
 
3.3.4 Specimen processing and evaluation 
3.3.4.1 Determination of fungal burden in organs and peritoneal lavage 
At time points indicated weighed sections of organs were homogenized in 1 ml of sterile PBS 
using an Ultra-Turrax homogenizer. Serial dilutions of the homogenates and PEL fluids 
(recovery of first lavage, see above) were plated on Sabouraud dextrose agar plates. Colonies 
of C. neoformans are soft, glistening to dull, smooth, usually mucoid, and creamy to slightly 
pink or yellowish brown in color and were counted after 48-72 hours of incubation at 30°C. 
Microscopical analyses showed that on Sabouraud agar, C. neoformans produces round, 
budding yeast cells. No true hyphae were visible.  
 
3.3.4.2 Histopathological analysis of livers 
Sections of livers were fixed in 4% buffered formalin. Further processing of samples was 
performed by Sharon Osborn, DNAX Research, Palo Alto, CA, USA. After embedment in 
paraffin wax, sections (5 µm) were stained with hematoxylin and eosin (H&E). Mucicarmine 
staining was performed for detection of cryptococci using muci-10 concentrate (American 
Master Tech Scientific, Inc, Lodi, CA, USA). Stained sections were evaluated 
microscopically by Dr. Scott E. Brodie, Schering Plough Corporation, Lafayette, NJ to 
determine the distribution, character and extent of granulomatous inflammation.  
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3.3.4.3 Immunohistochemistry of brain sections 
Brains were mounted on thick filter paper with Tissue Tek O.T.C. embedding media (Miles 
Scientific, Naperville, IL, USA), snap-frozen in isopentane (Sigma-Aldrich, Taufkirchen, 
Germany) precooled on dry ice and stored at -80o C according to a previous report 
(STENZEL et al. 2005). Specimen processing and immunohistochemical analysis were 
performed by Dr. Werner Stenzel, Institute of Neuropathology, University of Cologne, 
Germany. 10-μm thick frozen sections were prepared. The following rat anti-mouse 
monoclonal antibodies were derived from hybridomas obtained from the ATCC (Manassas, 
VA, USA): CD4 (clone GK.1.5), CD8 (clone 2.43), MHC class II (I-Ab,d,q haplotypes, clone 
M5.114.15.2), and Ly6-G (clone RB6-8C5). Immunohistochemistry was performed using the 
Vectastain® Elite® ABC-Kit (Vector Laboratories, Burlingame, CA, USA) with biotinylated 
secondary antibodies. The peroxidase reaction product was visualized using 3,3’-
diaminobenzidine (Sigma-Aldrich, Taufkirchen, Germany) as chromogen and H2O2 as co-
substrate. Consecutive histological sections were stained and evaluated microscopically. 
 
3.3.4.4 Quantitative RT-PCR 
Sections of the brain were snap-frozen in liquid nitrogen, transferred to dry ice and stored at -
80°C. Sample processing and quantitative PCR was performed by Terrill McClanahan and 
Wendy M. Blumenschein, DNAX Research, Palo Alto, CA, USA. Total RNA was prepared 
from frozen brain tissue using RNA STAT-60TM (Iso-Tex Diagnostics, Friendswood, TX, 
USA) which includes phenol and guanidinium thiocyanate in a mono phase solution. Brain 
samples were homogenized in the RNA STAT-60TM. Upon addition of chloroform, the 
homogenate separates into two phases: aqueous phase and organic phase. The total RNA 
remains exclusively in the aqueous phase while DNA and proteins are extracted into an 
organic phase and interphase. After isopropanol precipitation, total RNA was reextracted 
with phenol:chloroform:isoamyl alcohol (25:24:1) (Sigma-Aldrich, Taufkirchen, Germany) 
via phase-lock light tubes (Eppendorf, Hamburg, Germany). For mRNA analysis of PEC the 
RNeasy kit (Qiagen, Valencia, CA, USA) was used according to the manufacturer’s protocol 
with at least 5 × 106 PEC per sample.  
Total RNA (5 μg) was subjected to treatment with DNase (Ambion, Austin, TX, USA) to 
eliminate genomic DNA and then reverse-transcribed using the reverse transcriptase 
Superscript II (Invitrogen, Carlsbad, CA, USA) with oligo (dT)15 primers (Roche, Nutley, NJ, 
USA) and random hexamers (Promega, Madison, WI, USA). Cytokine-, chemokine- and cell 
marker-specific mRNA was measured using the designated primer pairs (Table 3) by real-
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time quantitative PCR (Taqman ABI 5700) with SYBR Green PCR Mastermix (Applied 
Biosystems, Foster City, CA). Gene expression levels were normalized to expression of the 
housekeeping gene ubiquitin for each sample; relative expression levels of infected mice 
were further normalized to naïve controls and compared between groups as x-fold 
upregulation. 
 
Gene Forward primer Reverse primer 
CD3 CCTCCTAGCTGTTGGCACTTG CCAGGTGCTTATCATGCTTCTG 
F4/80 GAGACGTTTGCCCTGAACATG AGGATCTGAAAAGTTGGCAAAGA 
IFN-γ GGATATCTGGAGGAACTGGCAA TGATGGCCTGATTGTCTTTCAA 
IL-1β TCGCAGCAGCACATCAACA ACAGCTTCTCCACAGCCACAAT 
IL-5 CTCACCGAGCTCTGTTGACAAG CCAATGCATAGCTGGTGATTTTTAT 
IL-17 ACCGCAATGAAGACCCTGAT CAGGATCTCTTGCTGGATGAGA 
MCP-1 GCTGGAGCATCCACGTGTT AGCCAGATGCAGTTAACGCCCCACT 
ubiquitin TGGCTATTAATTATTCGGTCTGCAT GCAAGTGGCTAGAGTGCAGAGTAA 
 
Table 3. Primer pairs used for Taqman RT-PCR analysis. 
 
3.3.4.5 Splenocyte cultures and ex vivo stimulation 
The characterization of the cytokine/chemokine pattern in the spleen in the course of 
systemic C. neoformans infection provides valuable insights into the immunological status of 
the host. Two approaches were used herein: (i) T cell functions were assessed by polyclonal 
stimulation as well as antigen-specific restimulation to characterize the type of Th response; 
(ii) In mice lacking T cells the activation state of APCs was assessed by stimulation via PRRs 
either with LPS or cryptococcal antigen. 
Therefore, spleens were passed through a 100-µm mesh. The retrieved splenocyte single 
cell suspension was cleared from red blood cells using RBC lysis buffer according to the 
manufacturer’s instructions, washed with RPMI 1640 cell culture medium, adjusted to 
5 × 106 cells per ml, plated in 24-well plates and stimulated after 2 hrs incubation at 37°C in a 
humidified CO2 enriched [5%] atmosphere. For polyclonal stimulation, wells were precoated 
with anti-CD3 (10 µg/ml) and washed before cells were added or Concavalin A (ConA, 5 
µg/ml) was added to splenocyte cultures. For antigen-specific restimulation, the weakly 
virulent acapsular C. neoformans strain CAP67, serotype D, was used as it was found to have 
better restimulatory capacities than the encapsulated strain 1841 (unpublished observation, 
BIONDO et al. 2005). Splenocytes were either stimulated with viable (106 cells per ml) or 
heat-killed (107 cells per ml) C. neoformans organisms. After 48 hrs incubation at 37°C in a 
humidified CO2 enriched atmosphere, supernatants were collected and stored at -20°C until 
assayed for cytokines and chemokines. 
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3.3.4.6 Flow cytometry 
3.3.4.6.1 Surface stain of PEC 
1 × 106 PEC per stained cell marker were transferred to Eppendorf reaction tubes and spun 
down at 300 × g for 10 min at 4°C. The supernatant was removed and the pellet then 
resuspended in FACS buffer (3% FCS, 0.1% NaN3 in PBS) containing 2 µg anti-mouse 
CD16/CD32 monoclonal antibody (Fc BlockTM, BD, Franklin Lakes, NJ, USA) in 10 µl 
buffer per 106 cells. After 1 hr incubation at 4°C, 10 µl of cell suspension (containing 106 
cells) was incubated with fluorophore-conjugated monoclonal antibodies each at 500 ng per 
1 × 106 cells (in FACS buffer) in V-bottom plates (BD, Franklin Lakes, NJ, USA). Incubation 
at 4°C for 15 minutes was followed by washing of cells three times with FACS buffer. The 
pellet was finally resuspended in fixation buffer. 
For each sample an unstained and an unspecific Ig isotype control was added. Single 
stained samples for each conjugated dye were generated on pooled cells of each experimental 
group for setting up the flow cytometer. 
 
3.3.4.6.2 Intracellular cytokine staining of splenocytes 
For intracellular cytokine staining, splenocytes were prepared and plated as described above 
and stimulated with plate-bound anti-CD3 plus soluble anti-CD28 (1 µg/ml) in the presence 
of Golgi-plug (according to BD PharMingen’s Cytofix/Cytoperm Plus kit instructions) for the 
final 4 hrs. This was followed by surface staining with anti-CD4 (FITC-labeled), 
permeabilization with Cytofix/Cytoperm buffer, and intracellular cytokine staining using anti-
IFN-γ (allophycocyanin-conjugated). Cells were analyzed with a FACScalibur flow 
cytometer. All antibodies and staining buffers were purchased from BD Biosciences, Franklin 
Lakes, NJ, USA. 
 
3.3.4.7 Cytokines and chemokines in peritoneal lavage fluids, splenocyte culture 
supernatants and sera 
Supernatants of splenocyte cultures, PEL fluids and brain homogenates as well as sera were 
assayed using LUMINEX xMAP® bead-based multiplexing technology. This technology has 
developed from the principles of a conventional sandwich ELISA but in contrast presents a 
possibility to detect multiple parameters simultaneously in one reaction (Fig. 3).  
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Fig. 3. Principle of LUMINEX xMAP technology. A, primary antibody coated beads are 
labeled with a fluorescent dye. Each bead-specificity is associated with a certain intensity of the 
dye and enables characterization of up to 100 different bead sets using a specific flow cytometer, 
the LUMINEX100 instrument. B, fluorescence-based determination of particular bead set and 
intensity of secondary antibody binding using LUMINEX100 instrument. 
 
As a direct result of this ability to multiplex the reactions, LUMINEX xMAP® technology 
confers a number of advantages over conventional ELISA-based procedures. These include 
high throughput screening and reduced reagent consumption and sample usage. The latter 
factor is of importance particularly when working with murine specimens as naturally only 
small sample amounts can be obtained from one animal. The use of a 12-plex reaction in the 
present study led to an 18-fold reduction of the amount of sample needed when compared to 
conventional ELISA thereby opening the possibility to screen for a broad range of target 
analytes in critical samples like sera or brain homogenate supernatants. 
In the present study the Beadlyte Mouse Multi-Cytokine Detection System 2 was used for 
detection of IL-1β, IL-2, IL-4, IL-5, IL-6, TNF-α, IFN-γ and customized with additional bead 
sets for IL-17 and MCP-1 detection. Following the manufacturer’s recommendations 
(Upstate Biotechnology, Lake Placid, NY, USA), the protocol was modified for the use of the 
high biotin-containing RPMI 1640 medium for analyses of splenocyte culture supernatants. 
When serum samples or supernatants of organ homogenates were assessed, the protocol was 
modified for the analysis of sera according to the manufacturer’s recommendations. In detail, 
50 µl of the diluted standards or samples as well as culture media or serum diluent as a 
negative control were added to each well with the addition of the cytokine capture antibody 
beads. After two hours incubation, plates were subjected to a vacuum manifold to control for 
high biotin in the medium. Reporter solution was added and incubated for 1.5 hrs. Diluted 
streptavidin-phycoerythrin solution was added to each well, and plates were incubated for 30 
 
Two lasers determine









Beads are filled with fluorescent 
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min. After stopping the reaction, plates were subjected to vacuum and after addition of assay 
buffer, read on the Luminex100 machine, which was programmed with specific bead-signature 
numbers representing the cytokines assayed. The instrument was set to read a minimum of 50 
events per bead set, and the median value was obtained for each reaction to minimize the 
effect of any outliers. 
 
3.3.4.8 Determination of IgE in sera 
The IgE concentration was determined by sandwich ELISA following a standard protocol 
using the capture antibody R32-72 (BD Pharmingen) and a biotinylated anti-mouse-IgE 
antibody (BD Pharmingen; R35-118) for detection after incubation with peroxidase-labeled 
streptavidin (Southern Biotech Assoc., Birmingham, AL, USA) and ABTS as substrate. 
 
3.3.4.9 Quantification of nitric oxide in sera  
NO in oxygen-containing solutions is chemically unstable and undergoes rapid oxidation to 
nitrite (NO2 ). The presence of various biological tissue components catalyzes this oxidation 
and promotes further oxidation of NO2  to nitrate (NO3 ). Therefore, it is necessary to 
measure both NO2  and NO3  to accurately determine the level of total NO. NO3  in sera 
was first reduced to NO2  by incubation the samples for 30 min with nitrate reductase 
(0.25 units/ml, Roche, Nutley, NJ, USA) in the presence of 100 µM NADPH (Roche, Nutley, 
NJ, USA). The concentrations of NO2  can be determined by Griess reagent reaction as 
described by STONE et al. (STONE et al. 2006). Therefore, the samples were incubated with 
a freshly prepared 1:1 working solution of Griess solution A and B for 10 minutes in the dark 
at room temperature. The plate was then read at 570 nm wavelength on a plate reader 
(Molecular Devices, Sunnyvale, CA, USA). 
 
3.3.5 Protein purification of p40-homodimer 
In collaboration with Dr. Samiya Al-Robaiy, BBZ, Institute of Immunology, University of 
Leipzig, and Karin vanderHeijden-Liefkens, Intervet, Boxmeer, Netherlands, murine p40 was 
expressed in Sf9 cells by infection with baculovirus carrying a p40-encoding plasmid. Sf9 is 
an insect cell line derived from Spodoptera frugiperda ovarian cells and is a natural host for 
baculovirus infection. This eukaryotic cell expression system was superior to prokaryotic 
systems (e.g. Escherichia coli expression) since eukaryotic expression allows for the 
glycolsylation of proteins which in the case of p40 is a prerequisite for its biological activity. 
Physiologically murine p40 is expressed in homodimeric (disulfide-bonded) as well 
monomeric form. Therefore, in the present work, homodimeric p40 had to be purified from 
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non-specific insect cell-derived proteins as well as monomeric p40 contamination using 
methods described below. 
 
3.3.5.1 SDS-PAGE 
By sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) proteins from a 
complex protein mixture are resolved by their molecular weight and can be visualized with 
different staining techniques (see below). Non-reducing SDS-PAGE was performed with 
10% polyacrylamide mini gels (11 cm × 7 cm × 0.1 cm) according to Laemmli (LAEMMLI 
1970). Protein samples were mixed with sample buffer in a 1:2 dilution and heated for 10 min 
at 85°C. The mini gel runs were performed at 127 V for the stacking gel and 200 V for the 
separating gel. Subsequently either silver staining was performed to depict the total proteome 
or Western blotting to visualize p40-specific proteins.  
 
3.3.5.2 Assessment of total protein content 
3.3.5.2.1 Quantification of total protein content 
Quantification of total protein content was achieved by using a bicinchoninic acid (BCA) 
protein assay kit (Pierce, Rockford, IL, USA) according to the manufacturer’s microwell 
plate protocol (detection limit: 5 µg/ml). Absorbance at 560 nm was measured on a plate 
reader (Molecular Devices, Sunnyvale, CA, USA). 
 
3.3.5.2.2 Qualitative analysis of total protein content by silver stain 
Silver staining is a very sensitive method for the in-gel detection of proteins. With the herein 
used SilverQuest staining kit (Invitrogen, Carlsbad, CA, USA) less than 10 ng of protein can 
be detected, whereas for other common stains like Coomassie staining the detection limit is 
about 50 times higher. Silver staining of SDS-gels was performed according to the 
manufacturer’s recommendations. Briefly, the SDS-gel was incubated in fixing solution for 
60 min. Then the gel was washed with 30% ethanol for 10 min and treated with the 
sensitizing solution provided in the kit for another 10 min. After washing with ultra-pure 
water, the staining occurred for 15 minutes in the silver-nitrate-containing staining-solution. 
Gels were washed for 45 seconds with ultra-pure water and incubated in the developing 
solution. When bands appeared in the desired intensity the procedure was stopped by addition 
of the stopper solution. After briefly washing with ultra-pure water, gels were scanned on a 
flat bed scanner (HP, Palo Alto, CA, USA). 
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3.3.5.3 Detection of murine p40 
3.3.5.3.1 Quantification of murine p40 
Quantitative determination of murine p40 in Sf9 cell culture supernatants and further 
preparations was performed by sandwich ELISA according to a standard protocol using a 
matching pair of mAb consisting of the mAb 5C3 (25 µg/ml) as capture and biotinylated 
polyclonal goat anti-mouse IL-12 (8 µg/ml) as detection Ab (both Abs were provided by Dr. 
M. Gately, Hoffmann-La Roche, Nutley, NJ, USA) combined with streptavidin-horseradish-
peroxidase (1:3000; Southern Biotechnology Associates), with recombinant mouse IL-12 and 
(p40)2 (provided by Dr. M. Gately, Hoffmann-La Roche, Nutley, NJ, USA) as a standard 
(detection limit: 80 pg/ml). 
 
3.3.5.3.2 Qualitative analysis of p40-proteins 
Distinguishing monomeric and homodimeric murine p40 was achieved by p40-specific 
Western blot. After running the samples over non-reducing 10% polyacrylamide gels proteins 
were transferred onto nitrocellulose membranes (MembraPure, Bodenheim, Germany). 
Therefore, the membrane and two sheets of Whatman paper were incubated in blotting buffer 








The gel was blotted onto the nitrocellulose membrane with 100V (60 min). Subsequently, 
membranes were briefly washed with TBS-T pH 10 and blocked for 1 hr with 3% gelatine in 
TBS-T pH 7.5. After another washing with TBS-T pH 10 membranes were incubated in 
biotinylated goat anti-mouse IL-12 mAb (4 µg/ml TBS-T pH 7.5 containing 1% gelatine) for 
1 hr. After three washes in TBS-T pH 10 membranes were incubated for 1 hr in horseradish 
peroxidase-conjugated streptavidin (diluted 1:100,000 in TBS-T buffer). Washing was 
repeated six times. Development was performed using the SuperSignal® WestPico enhanced 
chemiluminescence (ECL) kit (Pierce Biotechnology, Rockford, IL, USA) according to the 
manufacturer’s recommendations. Membranes were incubated for 1 min on HyperfilmTM-
ECL (Amersham Biosciences, Buckinghamshire, UK) or CL-Xposure film (Pierce 
Biotechnology, Rockford, IL, USA) in an x-ray cartridge. After exposure films were 
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developed using the wet laser imager (Scopix LR 5200, AGFA, Morstel, Belgium) of the 
radiology division in the Department of Small Animal Medicine, Faculty of Veterinary 
Medicine, University of Leipzig and scanned on a flat bed scanner (HP, Palo Alto, CA, 
USA). 
 
3.3.5.1 Liquid chromatography 
By liquid chromatography the murine p40-containing Sf9 cell culture supernatant was run 
through a solid phase and the eluent, murine p40, was retarded by the matrix. From the 
several liquid chromatography techniques applicable, in the present study ion-exchange 
chromatography (IEC) was performed since this method was reported previously for the 
purification of murine (p40)2 expressed in stably transfected CHO cells (GATELY et al. 
1996). By IEC proteins are separated by their surface charge which depends on the pH of the 
surrounding medium. The basic principle of IEC is illustrated in Fig. 4. In the present work a 
cation exchange chromatography was performed at pH 7.2 since murine p40 is positively 
charged at such pH. A linear salt gradient was used to displace bound protein from the 
column matrix dependent on the strength of binding. 
A 1-ml column with a CM Sepharose FF matrix (Amersham Biosciences, Buckinghamshire, 
UK) was used on the ÄKTAprime liquid chromatography system (Amersham Biosciences, 
Buckinghamshire, UK). 15 ml of Sf9 supernatant containing a total of 90 µg/ml mouse p40 as 
determined by ELISA was loaded on the column. After washing with 5 volumes of 20 mM 
sodium phosphate buffer pH 7.2 the column was eluted with a 40 ml linear salt gradient from 
0 mM to 500 mM NaCl in 20 mM sodium phosphate buffer pH 7.2. The eluate was collected 
in fractions of 1 ml and analyzed by SDS-PAGE followed by silver staining and Western blot 
analysis.  
 
3.3.5.4 Biological activity 
Since homodimeric p40 has been shown to be an antagonist for IL-12 at the IL-12 receptor 
(GILLESSEN et al. 1995; MATTNER et al. 1993), biological activity of the purified (p40)2 
was assessed in vitro by measuring its inhibitory effect on IL-12-induced production of 
IFN-γ. Splenocytes from WT mice (5 × 106 cells/ml) were incubated with (p40)2 in different 
concentrations ranging from 0.1 ng/ml to 100 ng/ml for 12 hrs and then stimulated with IL-12 
(1 ng/ml) for another 48 hrs. The cell supernatants were analyzed for IFN-γ by ELISA. 
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Fig. 4. Principle of ion exchange chromatography (IEC). Depicted is the principle of a cation 
exchange column as used for the purification of p40 in the present work. The column matrix has 
a negative charge thereby binding positively charged proteins such as homodimeric and 
monomeric p40 as well as irrelevant positively charged proteins (X) in the injected sample. The 
amount of positive charges determines the strength of binding to the matrix. By usage of a linear 
salt gradient, proteins are eluted in a certain time course depending on the strength of their 
binding. 
 
3.3.6 Statistical analysis 
Mann-Whitney-Rank sum test was used for comparisons of two groups. When comparing 
three or more groups, Kruskal-Wallis statistics followed by Dunns post test was performed. 
Survival proportions were displayed using the Kaplan-Meier method; statistical differences 
were assessed by the Log Rank test. Median survival times were compared using a paired 
Student’s t-test. In either case, GraphPad PRISM software was used (GraphPad Software 
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4 RESULTS 
 
4.1. CONTINUATION OF PREVIOUS STUDIES 
In a previous report it was shown that p40-deficient mice (which lack all p40-dependent 
IL-12 family members: IL-12, IL-23, p40, (p40)2) show a higher susceptibility to infection 
with C. neoformans than IL-12p35-/- mice (which lack only IL-12) (DECKEN et al. 1998). At 
this time point the existence of IL-23 was not known so that the authors suggested 
monomeric or homodimeric p40 to be the responsible cytokine for the observed difference. 
Reconstitution of p40-deficient mice with either factor, however, could not restore resistance 
to C. neoformans infection. This led the authors to hypothesize the existence of another p40-
dependent cytokine (DECKEN et al. 1998). The discovery of IL-23 in the year 2000 
suggested a candidate molecule to test this hypothesis (OPPMANN et al. 2000). 
 
4.1.1 Reconstitution of C. neoformans-infected p40-deficient mice with recombinant 
murine IL-23  
To address the question if the elevated susceptibility in p40-deficient mice to C. neoformans 
infection reported by DECKEN et. al. was due to the lack of IL-23, WT, IL-12p35-/- and p40-
deficient mice were infected with the C. neoformans serotype D strain 1841 as used in the 
previous study (DECKEN et al. 1998). The lack of IL-12 (IL-12p35-/- mice) was associated 
with a significantly reduced survival time (Fig. 5) consistent with a previous report 
(DECKEN et al. 1998). In addition, the combined lack of IL-12 and IL-23 (p40-deficient 
mice) resulted in an even shorter survival time (Fig. 5). Recombinant murine IL-23 (rmIL-23) 
or PBS was administered to p40-deficient mice beginning two days before infection, 
continued daily until day 20 post infection and twice a week thereafter. The administration of 
rmIL-23 resulted in a significantly prolonged survival period of p40-deficient mice as 
compared to their PBS-treated littermates (Fig. 5; P<0.001). IL-23 treated p40-deficient mice 
reached survival periods comparable to those of IL-12p35-/- mice (Fig. 5). Besides these 
effects on survival, rmIL-23 treatment resulted in a slightly reduced fungal load in liver and 
brain of p40-deficient mice at day 8 p.i. with C. neoformans (data not shown).  
These findings demonstrate a protective effect of recombinant IL-23 on the outcome of 
infection in IL-12/IL-23-deficient mice, strongly suggesting that IL-23 is the responsible 
molecule for the higher resistance of IL-12p35-/- mice compared to p40-deficient mice.  
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Fig. 5. IL-23 administration prolongs survival after C. neoformans infection in the 
absence of IL-12. The p40-deficient mice were treated with either rmIL-23 or PBS 
throughout the observation period of the experiment beginning two days before infection with 
10,000 CFU of C. neoformans. Survival of WT, IL-12p35-/- and reconstituted as well as mock-
treated p40-deficient mice (n = 8-10 mice) was monitored. Kaplan-Meier projections of 
survival curves were compared by log rank test. ***, P<0.001. The experiment shown is 
representative of two independently performed experiments. Another IL-23 reconstitution 
experiment using p40-/- mice showed similar results. 
 
4.2 THE ROLE OF ENDOGENOUS IL-23 IN EXPERIMENTAL CRYPTOCOCCOSIS 
The findings reported in the previous section indicate, that in mice lacking IL-12 the 
additional lack of IL-23 leads to reduced resistance to C. neoformans infection pointing to a 
role for IL-23 in immunity to C. neoformans. Further investigations focused on defining the 
particular contribution of endogenous IL-23 to immunity in cryptococcosis. Therefore, a 
series of in vivo experiments was performed in IL-23p19-/- mice, which specifically lack 
IL-23 but are still able to produce other p40-dependent cytokines, such as IL-12. The 
parameters which were assessed focused on (i) changes in resistance to C. neoformans 
infection, (ii) the type of immune response established in the course of C. neoformans 
infection, and (iii) the local inflammatory response at infected sites in mice lacking 
endogenous IL-23. 
 
4.2.1 Infection of IL-23p19-/- mice with C. neoformans: mortality and fungal burden 
To address the question if the specific lack of IL-23 but an unchanged ability to produce 
IL-12 renders mice more susceptible to C. neoformans infection, IL-23p19-/- were infected 
with C. neoformans. A major parameter to assess changes in resistance to infection of a 
specific mouse strain is the survival time. Therefore, in five independently performed 
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experiments survival was monitored. Comparing median survival periods of IL-23p19-/- and 
WT mice obtained in all five experiments, IL-23p19-/- mice showed a significantly reduced 
median survival time (P<0.05, Fig. 6 A). Statistics performed on each of the five experiments 
individually revealed a significantly reduced survival time of IL-23p19-/- mice in two 
experiments (P<0.05), and a trend for reduced survival times in IL-23p19-/- mice in three 
















































Fig. 6. Reduced survival of IL-23p19-/- mice following C. neoformans infection. 
IL-23p19-/- mice and WT controls were infected with C. neoformans. Survival was 
monitored through the course of infection. (A) Median survival times of WT and IL-23p19-/- 
mice in 5 independent experiments. Lines connect associated data points for either 
experiment. Statistics performed individually on each of the five experiments show a 
significantly reduced survival time of IL-23p19-/- in two experiments ( , P<0.05), the other 
three experiments ( ) including the depicted one (B) showed a trend for reduced survival 
times in IL-23p19-/- mice. *, P<0.05, n = 8-10 mice for each experiment. Median survival 
times were compared using paired t-test, survival curves were compared by Log Rank test as 
described in Materials and Methods. 
 
The reduction of the survival period observed in IL-23p19-/- mice was accompanied by a 
significant difference in cryptococcal clearance. At day 21 after infection, both IL-23p19-/- 
and WT mice had a comparable fungal burden in liver. However, on day 35 post infection, 
only WT mice showed a reduction of liver burden, whereas the fungal load in livers of 
IL-23p19-/- mice was similar to organ burden observed at day 21 p.i. (P<0.05, Fig. 7 A). At 
later time points no differences in liver burden were observed (data not shown) indicating that 
the lack of IL-23 leads to a delayed clearance of C. neoformans organisms in the liver. The 
fungal load of the brain was comparable between both genotypes at both time points (Fig. 7 
A B 
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B). Brain burdens tended to differ at day 49 after infection (without statistical significance) 











































Fig. 7. Delayed cryptococcal clearance in the liver of IL-23p19-/- mice. WT and 
IL-23p19-/- mice were infected with C. neoformans and sacrificed at day 21 and day 35 p.i. 
Colony forming units (CFU) in liver (A) and brain (B) were determined at both time points 
(bars indicate median). Mann-Whitney rank sum test was used for comparison of the two 
groups at either time point. *, P<0.05. Each data point represents one individual mouse. The 
data shown is pooled data from two independent experiments (n = 3 mice/experiment). 
 
These data indicate that even in the presence of IL-12, endogenous IL-23 contributes to 
resistance to C. neoformans, particularly at later time points. 
 
4.2.2 Cytokine pattern in sera and restimulated splenocytes of infected IL-23p19-/- mice 
Subsequent experiments aimed on exploring the basis for the increased susceptibility of 
IL-23p19-/- mice to C. neoformans infection. Protection in this infection model is shown to be 
strongly dependent on cellular immune mechanisms, underlining the importance of Th1 
promoting IL-12 effects (CASADEVALL and PERFECT 1998; NICHOLS et al. 1991). With 
IFN-γ as a marker cytokine for a Th1 response and IgE, the IL-4 dependent immunoglobulin 
class, as a marker for a Th2 response the Th1/Th2 balance was assessed in infected mice. 
Following infection with C. neoformans, IL-23p19-/- mice showed similar serum levels of IgE 
compared with WT controls at day 21 and 49 p.i. (Fig. 8 A). Furthermore, both IL-23p19-/- 
and WT mice had comparable amounts of circulating IFN-γ (Fig. 8 B). In contrast, p40-
deficient mice that additionally lack IL-12 show a clear Th2 shift by elevated serum IgE 
levels (P<0.05) and no detectable circulating IFN-γ (Fig. 8 A and B). 
In addition, when T cell functions were assessed at day 21 p.i. by restimulation of 
splenocytes of C. neoformans-infected mice with either a polyclonal stimulus (anti-CD3) or 
A B 
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antigen-specific stimuli such as viable (vCn) and heat-killed (hkCn) C. neoformans 
organisms, WT and IL-23p19-/- responded similarly with pronounced IFN-γ production. In 
contrast, IFN-γ expression in p40-deficient mice was significantly reduced after antigen-
specific stimulation (Fig. 8 C). In agreement with these findings, IL-4 levels were 
significantly higher in infected p40-deficient mice than in WT and IL-23p19-/- which showed 
similar IL-4 expression after polyclonal stimulation (Fig. 8 C).  
To specifically analyze Th cells in infected WT, IL-23p19-/- and p40-deficient mice, 
intracellular FACS staining of CD4+ T cells was performed for IFN-γ after anti-CD3/anti-
CD28 activation of splenocytes. The percentage of IFN-γ+ CD4+ T cells was comparable 
between WT and IL-23p19-/- mice, whereas p40-deficient mice showed a reduced frequency 
of CD4+ IFN-γ producers (Fig. 8 D). As IL-23 was shown to promote a distinct IL-17 
producing T cell subset (AGGARWAL et al. 2003; LANGRISH et al. 2005), the ability of 
splenocytes of infected WT, IL-23p19-/- and p40-deficient mice to produce IL-17 in response 
to polyclonal and antigen-specific stimulation was assessed. WT mice showed a pronounced 
IL-17 response after either stimulus. IL-17 production in IL-23p19-/- and p40- deficient 
splenocytes, however, was impaired when stimulated polyclonally and not detectable after 
antigen-specific restimulation with both viable C. neoformans (vCn) and heat-killed 
C. neoformans (hkCn) at day 21 (Fig. 8 C).  
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Fig. 8. Unaltered Th1/Th2 balance but impaired production of IL-17 in IL-23p19-/-. 
WT, IL-23p19-/- and p40-deficient mice were infected with C. neoformans and sacrificed or 
tail-bled at indicated time points. (A and B) Serum analysis for IgE (n=3-4 mice) were 
performed at days 21 and 49 p.i. (A) and for IFN-γ at day 35 p.i. Each data point represents 
one animal. (B). C, At day 21 p.i. pooled splenocytes of either genotype were plated at 
5 × 106 and stimulated in triplicates with anti CD3 (wells precoated with 5 µg/ml), 106 
viable (vCn) or 107 heat-killed (hkCn) C. neoformans organisms for 48 hrs. Culture 
supernatants were assessed for IFN-γ, IL-4 and IL-17 by LUMINEX multiplexing protein 
assay. D, At day 21 p.i. splenocytes of WT, IL-23p19-/- and p40-deficient mice were co-
stained for surface CD4 and intracellular IFN-γ after anti-CD3/anti-CD28 stimulation. Each 
dot represents the acquired signal of one single cell. Numbers in FACS blots indicate 
percentage of IFN-γ producers of all CD4+ lymphocytes. ANOVA was performed using 
Kruskal-Wallis statistics followed by Dunn’s post test. *, P<0.05. Experiments shown are 
representative of at least two independently performed experiments. 
 
At day 35 p.i. antigen specific induction of IL-17 was even more pronounced in WT mice, 
but still absent in mice lacking IL-23 (IL-23p19-/- and p40-deficient mice) (data not shown). 
The data demonstrate that the lack of IL-23 does not alter the Th1/Th2 balance in 
C. neoformans infection but leads to a significantly impaired IL-17 production. 
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4.2.3 Granuloma formation in the livers of infected IL-23p19-/- mice 
Protective immunity in C. neoformans infection is characterized by mononuclear cell 
recruitment to the site of infection leading to the formation of granulomata in most tissues 
(CASADEVALL and PERFECT 1998; MITCHELL and PERFECT 1995). Previously an 
impaired ability of p40-deficient mice to form granulomata when compared with IL-12p35-/- 
mice was reported (DECKEN et al. 1998). Since both genotypes of mice used in those 
studies lack IL-12, the following analyses focused on the individual contribution of IL-23 to 
the granulomatous response in cryptococcal infection in the presence of IL-12. Therefore, 
granuloma formation in the liver was compared between infected IL-23p19-/- and WT mice 
by light microscopy. 
As described above, liver burdens differed between the genotypes at day 35 p.i. but not at 
day 21 p.i. (see Fig. 7). For this reason the number of granulomata was normalized to the 
liver fungal burden by calculating the ratio between the mean number of granulomata per 
100x field and the colony forming units (CFU) in the liver for each animal. On day 21 after 
infection with C. neoformans no difference between WT and IL-23p19-/- mice could be 
found, whereas at day 35 p.i. WT mice had a significantly elevated normalized number of 
liver granulomata as compared with IL-23p19-/- mice (Fig 9). No significant differences were 
seen in terms of granuloma size or cellular composition in livers of infected WT and 












These findings provide evidence for a role of IL-23 in granuloma formation even in the 





































Fig. 9. Defective granuloma formation in the 
absence of IL-23. WT and IL-23p19-/- mice 
were infected with C. neoformans and the 
granulomatous response was quantified 
microscopically. Mean number of granulomata 
per 100× field was determined. To compensate 
for differences in organ burden the ratio of the 
number of granulomata and the organ burden in 
the liver was calculated for each animal as 
represented by depicted data points. *, P<0.05. 
Data shown is pooled data of two independently 
performed experiments (n = 3 mice per 
experiment). 
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4.2.4 Inflammatory response in brains of infected IL-23p19-/- mice 
C. neoformans shows a strong tropism for the CNS, causing a sustained meningoencephalitis 
which subsequently leads to death (CASADEVALL and PERFECT 1998; MITCHELL and 
PERFECT 1995). Therefore, it was of particular interest to investigate the inflammatory 
processes in the brain. Histopathological examination of brain sections at day 49 p.i. revealed 
a pronounced infiltration of the brain by C. neoformans organisms in both WT and IL-23p19-
/- mice. Cryptococcal foci were associated with leukocyte infiltrations in both genotypes (Fig. 
10 A and B). Interestingly, H&E stains of brain sections revealed a diminished inflammatory 
response in the IL-23p19-/- mice in four individually performed experiments. To verify this 
observation, the quality and composition of inflammatory cells was characterized by 
immunohistochemistry and the immunostained cell populations were quantified. 
Immunostaining for the activation induced cell surface molecule MHC-II revealed that in WT 
mice C. neoformans foci were surrounded by MHC-II-positive macrophages and abundantly 
activated MHC-II-positive microglia cells, whereas in the IL-23p19-/- mice macrophages 
were significantly less frequent and activation of microglial cells was markedly reduced (Fig. 
10 C, D and E). Differences in T cell recruitment were also obvious: IL-23p19-/- showed a 
reduction in CD4+ (Th cells) and CD8+ (CTL) T cells compared with WT mice (Fig. 10 F-K). 
Granulocytic leukocyte infiltration of the brain was greater in infected WT versus IL-23p19-/- 
mice when sections were evaluated using Gr1 staining (Fig. 10 L-N). 
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Fig. 10. Impaired activation of microglia and reduced cellular infiltration in brain 
tissue of infected IL-23p19-/- mice. Representative brain sections of either WT (A, C, F, I, 
L) or IL-23p19-/- (B, D, G, J, M) mice from day 49 p.i. with C. neoformans are shown to 
illustrate the granulomatous response. Stars indicate the location of cryptococcal foci. (A and 
B) H&E staining. In the brain parenchyma cryptococcal foci infiltrated by inflammatory 
cells were found in both WT (A) and IL-23p19-/- mice (B). Surrounding microglia cells were 
only visible in WT animals (arrows). (C and D) Anti-MHC-II immunostaining. Abundant 
MHC-II+ macrophages/microglia were found in the surroundings of cryptococcal foci in WT 
(C) and to a much lesser extend in IL-23p19-/- (D) mice (arrows indicate microglial cells). (F 
and G) Anti-CD4 immunostaining. In WT mice abundant CD4+ T cells were detected in the 
center and vicinity of cryptococcal foci (F) whereas in IL-23p19-/- mice only few CD4+ T 
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center and at the border of the cryptococcal foci in larger numbers in infected WT (I) than in 
IL-23p19-/- mice (J). (L and M) Anti-Gr1 immunostaining. In WT mice many Gr1+ 
granulocytes were found in the center and at the border of cryptococcal foci (L) whereas in 
IL-23p19-/- mice very few Gr1+ granulocytes were detected (M). (E, H, K and N), Diagrams 
show cell counts and statistical analysis referring to 10 evaluated high power fields (HPF) 
(0.16 mm2) in sections of the respective genotype. Sections shown are representative of four 
to six mice per group from one experiment. In four more individually performed 
experiments, H&E stained brain sections revealed a diminished inflammatory response. 
Original magnification, ×50.  
 
The results from the immunohistochemical analyses were supported by cell marker mRNA 
analyses of the brains. The levels of transcripts for the mononuclear cell markers F4/80 
(mainly found on macrophages) and CD3 (part of the T cell receptor) were reduced 
approximately 5-fold in brains from IL-23p19-/- mice as compared to brains from WT mice at 


























Fig. 11. Reduced expression of mRNA for mononuclear cell markers in brain tissue of 
infected IL-23p19-/- mice. WT and IL-23p19-/- mice were infected with C. neoformans and 
sacrificed at day 21 p.i. Expression of brain mRNA for F4/80 and CD3 was assessed by 
quantitative RT-PCR and normalized to ubiquitin expression. X-fold up-regulation is shown 
as a ratio between infected and naïve mice (pooled samples of 5 individual mice) of either 
genotype. Experiment shown is representative of two independently performed experiments. 
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To characterize the functional differences in the brain inflammatory response of both 
genotypes, the mRNA expression profile of cytokines and chemokines in the brain of infected 


















































































































Fig. 12. Reduced expression of proinflammatory cytokines and chemokines in brain 
tissue of infected IL-23p19-/- mice. WT and IL-23p19-/- mice were infected with 
C. neoformans. (A) Total mRNA of the brain was assessed for cytokine and chemokine 
expression at day 21 p.i. by quantitative RT-PCR. X-fold up-regulation normalized to 
ubiquitin is shown as a ratio between infected and naïve mice of either genotype (pooled 
samples of three individual mice). (B) Supernatants from brain homogenates were assessed 
for protein levels of IL-1β, IL-6, TNF-α, MCP-1, IFN-γ and IL-17 by LUMINEX 
multiplexing protein assay. Each data point represents one individual mouse. Experiments 
shown are representative of two independently performed experiments (n = 3 mice per 
experiment).  
 
At day 21 p.i., WT, but not IL-23p19-/- mice, showed increased expression of mRNA for the 
proinflammatory cytokine IL-1β and the mononuclear cell chemoattractant MCP-1. At this 
time point, however, the proinflammatory cytokines TNF-α, IL-6 and IFN-γ as well as the 
nitric oxide synthesizing enzyme iNOS were not expressed at appreciable levels (Fig. 12 A 
and data not shown). Similarly, elevated levels of MCP-1 protein were seen in brain 
homogenates of WT mice at day 21 p.i. Moreover, elevated levels of IL-1β and IL-6 protein 
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Remarkably such changes were more prominent at day 35 p.i. than on day 21 (Fig. 12 B). 
Although in models of autoimmunity IL-23p19-/- mice showed a markedly impaired 
production of TNF-α (CUA et al. 2003; MURPHY et al. 2003), in the brain homogenates of 
C. neoformans-infected mice this defect was not that obvious. There was no difference in 
IFN-γ levels when comparing the two genotypes and IL-17 was not detectable (Fig. 12 B).  
The data depicted in Fig. 12 are representative of a trend seen in 2 independent 
experiments but does not reach statistical significance. Nevertheless these data suggest an 
important mechanism for the significantly reduced cellular infiltration in brains of infected 
IL-23p19-/- mice (described in Fig. 10) and points to a role for MCP-1, IL-1β, and IL-6 in 
IL-23-dependent inflammation.  
Taken together, these findings demonstrate that the absence of IL-23 is associated with an 
impaired inflammatory response in the brains of mice infected with C. neoformans, mainly 
characterized by reduced recruitment and activation of mononuclear cells. 
 
4.3 EFFECTS OF EXOGENOUS IL-23 IN EXPERIMENTAL CRYPTOCOCCOSIS 
Infection studies in IL-23p19-/- mice described in the previous section revealed a contribution 
of endogenous IL-23 to resistance in C. neoformans infection by enhancing the cellular 
immune response and inducing a distinct cytokine pattern. In this section the above described 
proinflammatory activities of IL-23 are further explored by a distinct approach: Recombinant 
murine IL-23 was administered to C. neoformans-infected mice. This approach not only 
presents a possibility to further investigate the IL-23-induced mechanisms, but also to define 
a potential therapeutic activity of IL-23 treatment in chronic fungal infection. 
For all experiments in this section mice were infected intraperitoneally. The intraperitoneal 
infection led to a disease course similar to the disease course observed following intravenous 
infection (as stated in section 3.3.1.1), but opens the possibility for mechanistical analysis at 
the site of infection, the peritoneal cavity. In a first set of experiments the effect of exogenous 
IL-23 on the outcome of infection in WT mice was characterized. The main questions 
addressed were: (i) Does exogenous IL-23 improve resistance as assessed by monitoring 
survival period and determining fungal burden at infected sites? (ii) Which type of Th 
response is associated with effects mediated by IL-23 treatment? Subsequently, analyses were 
performed in p40-deficient mice to address the IL-23 effects specifically, and independent of 
the IL-12 pathway, and in T and B cell-deficient mice to investigate the effect of IL-23 on 
innate immunity. Parameters of interest in either immunodeficient mouse strain were (i) 
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fungal burden at the site of infection, (ii) cytokine and chemokine profile induced by 
C. neoformans and (iii) composition of inflammatory cell infiltrations at the site of infection. 
 
4.3.1 Administration of IL-23 to C. neoformans-infected WT mice 
To address the question if exogenous IL-23 mediates protective effects in cryptococcosis, 
WT mice were infected with C. neoformans and treated with IL-23, IL-12 (positive control) 
or PBS (negative control) starting two days prior to infection, continued daily until day 20 p.i. 
and twice a week thereafter.  
 
 


































































Fig. 13. Exogenous IL-23 enhances resistance to C. neoformans. C. neoformans-infected 
WT mice were treated with IL-23, IL-12 or PBS. (A) Mice were monitored for morbidity and 
mortality. (B) At day 8 p.i. the fungal burden in the peritoneal cavity was assessed. (C, D) At 
day 21 p.i. mice were sacrificed. Fungal burden of brain (C) and liver (D) were determined. 
Each data point represents one mouse. Data shown are representative (A, B) or cumulative 
data (C, D) of two individually performed experiments (n = 5-8 mice per experiment). Bars 
in scatter plots indicate median. **, P<0.01; *, P<0.05. 
 
At day 100 p.i. 78% of mock-treated mice had died whereas, consistent with a previous report 
(DECKEN et al. 1998), IL-12 treatment resulted in 100% survival during the complete 
observation period (Fig. 13 A). The administration of IL-23 led to significantly prolonged 
survival periods compared to the PBS treatment; however 40% of IL-23-treated WT mice 
died up to day 100 p.i. (Fig. 13 A). Both, IL-23 and IL-12 treatment resulted in reduced 
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fungal burden in livers and brains was comparable between all three treatment groups at this 
time point (data not shown). At day 21 p.i. however, cryptococcal burden in brain and liver 
was significantly reduced in IL-23-treated WT mice compared to the mock-treated controls 
(Fig 13 C and D). 
Analysis of sera at day 21 p.i. revealed a pronounced production of the Th1 associated 
cytokine IFN-γ as well as TNF-α and the effector molecule nitric oxide (NO) following IL-12 
treatment, whereas serum levels of these factors were below detection limit following either 
IL-23 or PBS treatment (Fig. 14 A-C). In contrast, a significant production of the Th2-
associated immunoglobulin class IgE was found in the IL-23- and the PBS-treated group at 
comparable levels but not in the IL-12-treated group (Fig. 14 D). This Th2 shift after IL-23 or 
PBS treatment, as well as the Th1 cytokine expression following IL-12 treatment was evident 
already at day 8 p.i. (data not shown). IL-17 was not detectable in sera at either time point 
(data not shown). 
















































Fig. 14. Exogenous IL-23 does not alter the Th1/Th2 balance in C. neoformans infection. 
C. neoformans-infected WT mice were treated with IL-23, IL-12 or PBS. At day 21 p.i. sera 
were assessed for cytokines, nitric oxide and IgE. Each data point represents one animal. 
Experiment shown is representative of two individually performed experiments (n = 5-8 
mice). Bars in scatter plots indicate median. **, P<0.01; *, P<0.05. 
 
Taken together, administration of either IL-12 or IL-23 was associated with enhanced 
resistance to C. neoformans infection as determined by prolonged survival rates and reduced 
fungal burden early at the site of infection (day 8 p.i.) as well as later (day 21 p.i.) in infected 
organs. The importance of IL-12 in immunity to intracellular infection and its association 
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treated mice despite their elevated resistance failed to mount a protective Th1 response but 
show a default Th2 pattern. 
 
4.3.2 Administration of IL-23 to C. neoformans-infected p40-deficient mice 
4.3.2.1 Fungal burden at site of infection and cytokine profile 
To investigate the mechanisms by which exogenous IL-23 mediates its protective effects 
subsequent experiments explored the processes that led to the observed IL-23- induced 
reduction of fungal burden in the peritoneal cavity. To see whether the protective action of 
administered IL-23 depends on IL-12, studies were performed in p40-deficient mice that lack 
























































Mice were intraperitoneally infected with C. neoformans and treated with either IL-23 or 
PBS. At day 8 p.i. IL-23-treated p40-deficient mice showed a reduction of fungal burden at 
the site of infection, the peritoneal cavity (Fig. 15 A). Surprisingly, IL-23 treatment resulted 
in elevated protein levels of the commonly Th2-associated cytokine IL-5 in PEL fluids 




Fig. 15. Exogenous IL-23 leads to reduced 
fungal burden in C. neoformans-infected 
p40-deficient mice and enhanced expression 
of IL-5 and IL-17 at the site of infection. 
p40-deficient mice were infected 
intraperitoneally with C. neoformans and 
treated with either IL-23- or PBS. (A) Fungal 
load in the PEL fluid was determined at day 8 
p.i. (B) Supernatants of PEL fluids from IL-23- 
or mock-treated p40-deficient mice were 
analyzed for cytokines at day 8 p.i. IL-5 was 
detected by LUMINEX multiplexing protein 
assay. (C) PEC of three mice per treatment 
group (red-labeled data points in panel A and 
B) were pooled and total mRNA was analyzed 
for cytokine expression by quantitative RT-
PCR at day 8 p.i. X-fold upregulation 
normalized to ubiquitin is shown. Data shown 
are cumulative data of two individually 
performed experiments for either genotype (n = 
3-5). Bars in scatter plots indicate median. **; 
P<0.01; *P<0.05. 
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protein was not detectable in the PEL fluids (data not shown).Protein levels of IFN-γ, TNF-α, 
IL-6, IL-1β, IL-2, IL-4 and MCP-1 in PEL fluids and mRNA levels of those factors in PEC 
did not differ between IL-23 and PBS treatment groups (data not shown).  
According to the elevated mRNA levels, the cryptococcal antigen specific recall response 
in splenocyte cultures was characterized by an elevated protein expression of IL-17 and IL-5 
in the IL-23 treated group (Fig. 16). Moreover, elevated levels of the proinflammatory 
cytokines IL-1β, TNF-α, IL-6 and IL-2 showed in the IL-23-treated group after stimulation 
with either viable (vCn) or heat-killed cryptococci (hkCn). In case of IL-17 and IL-5 the 
difference in production level between treatment groups was even more pronounced when 
cells were stimulated with a polyclonal stimulus (ConA) (Fig. 16).  
 



















































































Fig. 16. Enhanced production of proinflammatory cytokines and IL-5 in restimulated 
splenocytes of IL-23-treated p40-deficient mice infected with C. neoformans. At day 8 
p.i. pooled splenocytes from IL-23- or mock-treated p40-deficient mice (n = 5 mice) were 
plated and stimulated in triplicates with ConA (5 µg/ml), 106 viable (vCn) or 107 heat-killed 
(hkCn) C. neoformans organisms per ml. Culture supernatants were assessed for IL-1β, IL-6, 
TNF-α, IL-17, IL-5 and IL-2 by LUMINEX multiplexing protein assay and results are 
shown as mean and SEM. Experiment shown is representative of two individually performed 
experiments. 
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The data indicate that the IL-23 treatment can lead to a reduction of fungal burden at the site 
of infection independent of IL-12. This effect was associated with an elevated local 
production of IL-17 and IL-5. A pronounced expression of both cytokines was also seen in 
stimulated splenocyte cultures. In addition, splenocytes of IL-23-treated mice showed a 
pronounced expression of other proinflammatory cytokines and chemokines.  
 
4.3.2.2 Cellular immune response at the site of infection 
The magnitude and composition of the cellular immune response determine the degree of 
protection in C. neoformans infection (CASADEVALL and PERFECT 1998; MITCHELL 
and PERFECT 1995; NICHOLS et al. 2002). In the previous section mice lacking 
endogenous IL-23 were shown to develop an impaired cellular response to C. neoformans 
infection. To assess the effect of exogenous IL-23 on cellular composition of the 
inflammatory cell infiltrations at infected sites, PEC were taken from IL-23- and mock-
treated p40-deficient mice 8 days after intraperitoneal infection with C. neoformans. Total 
cell counts were comparable between both treatment groups (Fig. 17 A). Cellular 
composition of PEC was analyzed by flowcytometry. A comparison of PEC from both 
treatment groups by size and granularity did not reveal apparent differences (Fig. 17 B). 
When gating on lymphocytes (red gate in Fig. 17) it turned out that IL-23 treatment resulted 
in a significantly higher frequency of TCR-β+ cells. Interestingly, the same trend was seen for 
NK1.1+ cells (Fig. 17 C). The percentage of CD11c+ cells (mainly DCs) of all viable PEC 
(blue gate in Fig. 17) was significantly higher in the IL-23-treated group (Fig. 17 D) whereas 
F4/80+ (mainly macrophages) and Gr1+ (mainly granulocytes) cells did not differ in 
frequency (data not shown). 
These findings underline the implication of endogenous IL-23 in cellular immunity by 
demonstrating an IL-23-induced enhancement of T cell and DC frequency at the site of 
infection. These effects are mediated independently of IL-12 or other p40 cytokines. 
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Fig. 17. Exogenous IL-23 augments infiltration of T cells and DCs to the site of infection 
in p40-deficient mice infected with C. neoformans. PEL fluids were obtained from IL-23- 
or mock-treated p40-deficient mice at day 8 after intraperitoneal infection with 
C. neoformans. (A) Total number of cells in PEL fluid was assessed microscopically. (B-F) 
Cellular composition of PEL fluids was determined by flow cytometry (FACS). (B) 
Representative FACS plots showing PEC of p40-deficient mice after IL-23 or mock 
treatment by size (forward scatter, FSC) and granularity (side scatter, SSC), each dot 
represents the signal of one cell. (C) Frequency of TCR-β+ and NK1.1+ cells in PEC is shown 
as percentage of all lymphoid cells (red gate in panel B). Representative FACS dot plots 
show percentage of NK1.1+ (upper left quadrant) and TCR- β+ (lower right quadrant) cells. 
(D) Frequency of CD11c+ cells is shown as percentage of all viable PEC (blue gate in panel 
B). Representative FACS histogram plots show isotype control (open curve) and cells stained 
for CD11c (filled curve). Bars indicate analysis region for CD11c+ cells. Scatter plots show 
cumulative data of two individually performed experiments (n = 3-5 mice in each 
experiment). Representative FACS plots show representative data of one mouse per 
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4.3.3 Administration of rmIL-23 to C. neoformans-infected mice lacking T and B cells 
4.3.3.1 Fungal burden at site of infection and cytokine/chemokine profile 
The innate immune system is the first line of defense against invading pathogens. In 
cryptococcosis innate immunity plays an important role in containing the infection 
(MITCHELL and PERFECT 1995). Previous experiments showed that IL-23 enhances the 
inflammatory response independent of the major Th1 cytokine IL-12, but associated with a 
pronounced antigen specific production of IL-17. To address the question if IL-23 actions 
completely rely on such T cell dependent mechanisms, it was of interest to investigate also 
the effects of IL-23 on innate immunity. Therefore, RAG-deficient mice (RAG1-/- or RAG2-/-
) that lack T and B cells were infected with C. neoformans intraperitoneally. At day 8 p.i. 
IL-23-treated RAG-deficient mice had a significantly reduced fungal burden at the site of 























Moreover, expression of proinflammatory cytokines such as IL-1β, IL-6 and TNF-α as well 
as IL-5 and the chemokine MCP-1 were strongly enhanced after IL-23 treatment, in contrast 
to IFN-γ which was not elevated in either group (Fig. 19). Paralleling these findings, an ex 
vivo analysis of the activation of innate immune cells in the spleen revealed a pronounced 
expression of IL-1β, IL-6 and TNF-α, IL-5, MCP-1 and IL-17 in IL-23-treated RAG-
deficient mice (Fig. 20). 
These data indicates that the reduction of fungal burden at the site of infection by IL-23 
treatment is independent of T and B cells. In addition, the elevated cytokine and chemokine 
expression at the site of infection as well as in stimulated splenocyte cultures does not rely on 
the means of adaptive immunity. 
Fig. 18. Exogenous IL-23 leads to reduced 
fungal burden at the site of infection in T 
and B cell deficient mice infected with 
C. neoformans. RAG-deficient mice were 
infected intraperitoneally with C. neoformans, 
treated with either IL-23 or PBS and sacrificed 
at day 8 p.i. Fungal load in PEL fluids was 
determined. Data shown are cumulative data 
of two individually performed experiments. 
Bars indicate median. n = 5-6 mice per 
experiment. *, P<0.05.
RESULTS 










































































Fig. 19. Exogenous IL-23 enhances cytokine and chemokine production at the site of 
infection in T and B cell deficient mice infected with C. neoformans. RAG2-/- mice were 
infected intraperitoneally with C. neoformans, treated with either IL-23 or PBS and 
sacrificed at day 8 p.i. Supernatants of PEL fluids were assessed for IL-1β, IL-6, TNF-α, 
IL-5, MCP-1 and IFN-γ by LUMINEX multiplexing protein assay. Experiment shown is 
representative of two individually performed experiments. n = 5-6 mice. Bars indicate 
median. **, P<0.01. 
 














































































Fig. 20. Exogenous IL-23 enhances cytokine production in restimulated splenocytes 
from C. neoformans-infected mice lacking T and B cells. At day 8 p.i. splenocytes from 
IL-23- or mock-treated RAG1-/- mice (n = 5) were pooled, plated and stimulated in triplicates 
for 48 hr with LPS (5 µg/ml), 106 viable (vCn) or 107 heat-killed (hkCn) C. neoformans 
organisms per ml. Culture supernatants were assessed for IL-1β, IL-6, TNF-α, IL-17, IL-5 
and IL-2 by LUMINEX multiplexing protein assay and results are shown as mean and SEM. 
Experiment shown is representative of two individually performed experiments. 
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Fig. 21. Exogenous IL-23 augments inflammatory cells infiltration to site of infection 
and enhances activation of F4/80+ PEC in mice lacking T and B cells. PEL fluids were 
obtained from C. neoformans-infected IL-23- or mock-treated RAG2-/- mice at day 8 p.i. (A) 
Total number of cells in PEL fluid was assessed microscopically. (B-H) Cellular composition 
of PEC was determined by flow cytometry. (B) Representative FACS plots of PEC by size 
(FSC) and granularity (SSC). Frequency of NK1.1+ (C) is shown as percentage of small sized 
non-granular cells (red gate in panel B). Although RAG-deficient mice are lacking mature T 
and B lymphocytes, besides NK cells this gate contains leukocyte precursors, C. neoformans 
organisms and less defined leukocyte subpopulations. Moreover, the gate overlaps with DC, 
granulocyte and macrophage containing regions. CD11c+ (D), Gr1+ (E) and F4/80+ (F) cells 
is shown as percentage of all viable PEC (blue gate in panel B). (G) Rate of F4/80high cells is 
shown as percentage of total F4/80+ PEC. (H) F4/80+ cells were gated (indicated regions in 
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histogram plots in panel F) and frequency of CD86+ F4/80+ cells was determined. 
Representative FACS plots refer to the data points labeled red in scatter plots. Histogram 
plots show isotype control (open curve) and cells stained for indicated cell surface antigens 
(filled curves); regions of positively stained cells are indicated by bars. Experiment shown is 
representative of two individually performed experiments (n = 6 mice). **, P<0.01; *, 
P<0.05. 
 
4.3.3.2 Cellular immune response at the site of infection 
In a next step the cellular basis for the local IL-23-dependent antifungal effect and the 
associated enhanced cytokine and chemokine expression was explored. Therefore, PEC of 
IL-23- or mock-treated RAG-deficient mice were analyzed at day 8 p.i. Total cell counts 
were no different between both treatment groups (Fig. 21 A). Moreover, analysis for size and 
granularity of PEC in both treatment groups showed no difference (Fig. 21 B). Staining for a 
number of cell type specific surface antigens, however, revealed a higher percentage of 
NK1.1+ (mainly NK cells, Fig. 21 C), CD11c+ (mainly DCs, Fig. 21 D) and Gr1+ (mainly 
granulocytes, Fig. 21 E) cells when gated on viable PEC. The frequency of F4/80+ cells 
(mainly macrophages) was comparable in both treatment groups (Fig. 21 F), however, further 
analysis of these cells revealed morphological differences: A higher frequency of F4/80+ cells 
expressed F4/80 at a high level (Fig. 22 G) and, in addition, the expression of the co-
stimulatory molecule CD86 by F4/80+ cells was significantly higher following IL-23 
treatment (Fig. 21 H). 
These findings confirm the effect of IL-23 on DC recruitment observed in p40-deficient 
mice. Additionally, they reveal its independence of T and B cells. In such immunodeficient 
conditions, the effects of exogenous IL-23 on inflammatory cell recruitment are even more 
prominent, as the frequency of NK cells and granulocytes was elevated.  
 
4.4 PROTEIN PURIFICATION OF P40-HOMODIMER 
Cytokines of the IL-12 family are considered the most important group of APC-produced 
cytokines orchestrating cellular immune responses (ALBER et al. 2006; BROMBACHER et 
al. 2003; LANGRISH et al. 2004; TRINCHIERI et al. 2003). In the current understanding of 
the interplay between IL-12 family cytokines, however, many questions remain unsolved. 
Homodimeric p40 has been shown to antagonize IL-12 effects in vitro (GILLESSEN et al. 
1995; MATTNER et al. 1993) and in vivo (MATTNER et al. 1997), but was also associated 
with proinflammatory agonistic effects (HOLSCHER et al. 2001). In addition, in a very 
recent report homodimeric p40 could be shown to impair IL-23-induced IL-17 production 
(SHIMOZATO et al. 2006). The herein described protein purification of homodimeric p40 
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from transfected insect cell culture supernatants forms the basis for a future series of in vivo 
and in vitro studies that aim to provide a deeper insight in the networking of all p40-
dependent cytokines. The insect cell line Sf9 was transfected with a murine p40-encoding 
plasmid by a baculovirus vector in collaboration between the Institute of Immunology and 
Intervet, Boxmeer, The Netherlands. Supernatants of transfected cell cultures were provided 
for the herein described purification. 
 
4.4.1 Expression level of (p40)2 in Sf9 cell culture supernatants 
In a first step the protein profile and the expression of murine p40 in Sf9 cell culture 
supernatants was characterized. The total protein content was 2 mg/ml. The proteome of Sf9 







Fig. 22. Analysis of p40 content in Sf9 cell culture supernatants. A non-reducing SDS-
PAGE was performed with cell culture supernatant from p40-transfected Sf9 cells. (A) By 
silver-staining the proteome of the supernatants was visualized. (B) p40-specific Western 
blot developed by chemiluminescence and visualized on x-ray film. Sf9, Sf9 cell culture 
supernatants; Numbers, dilution factor; M, molecular weight marker; bold arrow, (p40)2 at 
116 kDa; thin arrow, p40 at approximately 45 kDa. 
 
As determined by ELISA the concentration of murine p40 in Sf9 culture supernatants was 6 
µg/ml. The expression of p40 was further characterized by p40-specific Western blot (Fig. 22 
B). Besides a strong band at 116 kDa consisting of p40-homodimer another intense band 
showed at 40 kDa referring to monomeric p40. Interestingly, at approximately 97 kDa a 
further band showed that in size does not match yet reported p40-cytokines (Fig. 22 B). The 
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ratio between homodimeric and monomeric p40 was estimated as 2:1 by comparing the 
intensity of the bands that showed in the p40-specific Western blot. 
Taken together, transfection of Sf9 cells by baculovirus containing a p40-encoding 
plasmid resulted in a strong expression of homodimeric as well as monomeric p40. 
 
4.4.2 Ion exchange chromatography of Sf9 cell culture supernatants 
In a previous report, GATELEY et al. achieved purification of murine p40 expressed by 
stably transfected CHO cells by ion exchange chromatography. As murine p40 has a positive 
charge in a neutral pH it can be bound to a negatively charged matrix. Therefore, a cation 
exchange column packed with a matrix bearing free carboxylgroups was used in combination 
with a liquid chromatography system. A total amount of 90 µg of murine p40 was loaded on 
the column. By washing with five volumes of sodium phosphate buffer most of the 
negatively charged and therefore unattached protein was eliminated from the column (data 
not shown). Subsequently, the column was eluted with a 40 ml linear salt gradient from 0 







The positively charged Na+ ions compete with the proteins of the Sf9 cell cultures for the 
binding sites on the column matrix. With rising salt concentration even strongly attached 
protein is removed from the column. The resulting chromatogram showed two protein peaks 
during the elution process (Fig. 23).  
 
Fig. 23. Ion-exchange chromatography of 
Sf9 cell culture supernatants containing 
(p40)2. Purification of murine p40-
homodimer from transfected Sf9 cells was 
achieved by ion exchange chromatography 
using a negatively charged matrix. Sf9 culture 
supernatant containing 90 µg total murine p40 
was loaded on the column. After washing off 
non-bound protein the column was eluted 
with a linear salt gradient ranging from 0 mM 
to 500 mM. The red line in the chromatogram 
displays the salt concentration, the blue line 
the absorption at 260 nm wavelength 
measured in the eluate. Arrows indicate 
protein peaks.  
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Fig. 24. Ion-exchange chromatography of p40-containing Sf9 cell culture supernatants. 
The eluate obtained by cation exchange chromatography was collected in fractions of 1 ml 
volume. Total protein and p40 content in selected fractions was analyzed by non-reducing 
SDS-PAGE followed by silver staining (A) or p40-specific Western blot (B). The fractions 
analyzed are depicted in the chromatogram on the right side of both panel A and B. Non-
reducing SDS-PAGE and subsequent silver-staining (C) and p40-specific Western blot (D) 
of pooled fractions #31-40 (p), after 10-fold concentration (filtrate = f; retentate = r) and 
subsequent sterile filtration (s). Numbers, number of fraction; M, molecular weight marker; 
bold arrow, (p40)2; thin arrow, monomeric p40. 
 
The eluate was collected in fractions of 1 ml which were analyzed by SDS-PAGE followed 
by silver staining (Fig. 24 A) and p40-specific Western blot analysis (Fig. 24 B). This 
analysis revealed that the first peak recorded in the chromatogram (Fig. 23) referred to 
monomeric p40 and other cationic proteins, whereas the second peak reflected homodimeric 
p40. Homodimeric p40 containing fractions without detectable contamination of monomeric 
p40 (fractions #31-40) were pooled, concentrated 10-fold and subsequently sterile-filtered. 
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Protein purity of the final preparation was assessed by non-reducing SDS-PAGE followed by 
silver-staining (Fig. 24 C) or p40-specific Western blot (Fig. 24 D). Since no monomeric p40 
was detected in the final preparation the p40-concentation of 5 µg/ml as determined by 
ELISA referred in total to homodimeric p40. This was further confirmed by assessing the 
amount of total protein in the final preparation (5 µg/ml).  
In summary, homodimeric p40 could be purified from Sf9 culture supernatants and 
distinguished from monomeric p40 and other p40-independent proteins by ion exchange 
chromatography. 
 
4.4.3 Biological activity of purified (p40)2 
An important step at the end of the purification process is the determination of the biological 
activity of the purified protein. Since homodimeric p40 has been shown to be an antagonist 
for IL-12 at the IL-12 receptor (MATTNER et al., 1993) biological activity of the purified 
(p40)2 was assessed in vitro by measuring its inhibitory effect on IL-12-induced production 
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Fig. 25. Determination of biological activity of purified Sf9 cell culture supernatant 
(p40)2. Biological activity of purified (p40)2 was measured in vitro by determination of its 
inhibitory effect on IL-12 induced IFN-γ production. Cells were incubated with different 
concentration of p40-homodimer. After 12 hrs IL-12 (1 ng/ml) was added. IFN-γ was 
assessed in culture supernatants after 48 hrs. As controls splenocytes were stimulated with 
medium only as well as either cytokine individually. Black bars, purified Sf9 cell-derived 
(p40)2; grey bars, CHO cell-derived (p40)2 as a control. 
med 100 0.1 1 10 1 100  
(p40)2 [ng/ml] 
IL-12 [1 ng/ml] IL-12 [1 ng/ml] 
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Therefore, primary splenocytes from WT mice were incubated with different concentrations 
of the purified Sf9-cell derived homodimeric p40 as well as CHO cell-derived homodimeric 
p40 as a control. Cells were incubated for 12 hrs with homodimeric p40 before addition of 
IL-12 to ensure sufficient binding of homodimeric p40 to the IL-12 receptor. After 48 hrs 
IFN-γ was measured in the culture supernatants. This assay showed that purified Sf9 cell-
derived (p40)2 blocked IL-12 activity in a dose-dependent manner and to a similar extent as 
seen for the CHO-derived (p40)2-control (Fig. 25). This data demonstrates that bioactive p40-
homodimer could be purified from Sf9 cell culture supernatants. 
 
4.4.4 Comments on p40 protein purification yields 
The above purification procedure resulted in highly purified and bioactive murine (p40)2. 
Assuming that the amount of (p40)2 in the Sf9 cell supernatants is half the amount of total 
p40 (which is 6 µg/ml), approximately 1/9 of the (p40)2 loaded on the column could be 
recovered. To purify an appropriate quantity of (p40)2 for in vivo and in vitro use, e.g. 10 mg, 
the rate of recovery would have to be improved. Since the resolution of the ion-exchange 
chromatography can barely be enhanced, it is recommended to take the eluate achieved by 
ion-exchange chromatography for a further purification step. The difference in molecular 
weight between monomeric and homodimeric p40 is large enough to perform a gel filtration 
over Sephacryl S-200 HR (Amersham) utilizing the same liquid chromatography system as 
described above. Thereby those fractions containing homodimeric p40 contaminated with 
monomeric p40 could be finally purified. 
RESULTS 
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5 DISCUSSION 
 
The IL-12 family of cytokines plays a key role in the orchestration of cellular immune 
responses. Years of basic and clinical research on the prototypical Th1 cytokine IL-12 
revealed its importance in immunity to intracellular nonviral infections, cancer and 
autoimmune diseases (ALBER et al. 2006; TRINCHIERI 2003). After the discovery of IL-23 
and its structural relationship to IL-12, re-analysis of IL-12 studies revealed, that IL-23, 
rather than IL-12, is the key player in autoimmune disease models (CUA et al. 2003; 
MURPHY et al. 2003), inducing a non-classical T helper cell population that is mainly 
characterized by the production of IL-17. Knowing about this strong proinflammatory 
potential of IL-23 it is intriguing to investigate its role in infectious diseases. In a series of in 
vivo experiments the present work aimed to explore the contribution of the novel IL-23-
induced immune pathway to host defense in chronic fungal infection. A protective function of 
IL-23 in the absence of IL-12 could be identified by reconstitution of p40-deficient mice with 
recombinant IL-23. In addition, the presented results describe a role for endogenous IL-23 in 
protective immunity even in the presence of IL-12. Corroborating theses findings, 
administration of recombinant IL-23 enhanced the inflammatory response to C. neoformans 
infection and improved elimination of fungal cells even in the absence of T and B cells.  
  
5.1 IL-23 IS PROTECTIVE IN THE ABSENCE OF IL-12 
It has been shown previously that p40-deficient mice are more susceptible to infection with 
the opportunistic pathogen C. neoformans than IL-12p35-/- mice (DECKEN et al. 1998). 
Survival times and organ burden of p40-deficient mice could not be restored by treatment 
with either monomeric or homodimeric p40 (DECKEN et al. 1998), which are produced 
physiologically in a large excess relative to IL-12 or IL-23 (D'ANDREA et al. 1992). In the 
present study, administration of recombinant IL-23 greatly improved the survival of infected 
p40-deficient mice, restoring the survival period of treated mice to the level of IL-12p35-/- 
mice. Collectively, these data indicate that IL-23 has a role in resistance to C. neoformans 
infection, although IL-23 is not sufficient for complete protection in the absence of IL-12. 
Recently, a similar effect was attributed to IL-23 reconstitution in Toxoplasma gondii 
(T. gondii)-infected p40-deficient mice (LIEBERMAN et al. 2004). These data demonstrate 
that IL-23 is able to protect against C. neoformans and T. gondii independently of IL-12. 
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5.2 A ROLE FOR ENDOGENOUS IL-23 IN IMMUNITY TO C. NEOFORMANS 
INFECTION 
The use of genetically modified mice provides an essential and broadly used tool for the 
understanding of the function(s) of a particular gene product. To define the contribution of 
endogenous IL-23 to immunity in cryptococcosis in the present work, parameters of infection 
were assessed in mice deficient for IL-23p19. These mice were generated by targeted gene 
disruption in 129/SvEv stem cells (OPPMANN et al. 2000). Thus bred mice were 
backcrossed onto a C57BL/6 background. C57BL/6 mice are broadly accepted to be a Th1 
biased strain. To infection with the herein used C. neoformans strain 1841 C57BL/6 mice 
were shown to be relatively resistant (DECKEN et al.). For the present study the infectious 
dose was optimized for the use of this mouse strain and chronic lethal infection was induced.  
 
5.2.1 IL-23 contributes to immunity to C. neoformans infection in the presence of IL-12 
The shorter survival time and higher organ burden observed in C. neoformans-infected 
IL-23p19-/- compared to WT C57BL/6 mice provide evidence for a role of endogenous IL-23 
in host resistance. Interestingly, IL-23p19-/- mice infected with T. gondii did not show an 
altered resistance after infection (LIEBERMAN et al. 2004). This may be related to the 
different nature of T. gondii versus C. neoformans infection and, in addition, only acute 
stages of infection were investigated in this study (LIEBERMAN et al. 2004). In the present 
studies of C. neoformans infection both early and late time points were examined. It was 
found that in IL-23p19-/- mice clearance of C. neoformans organisms is delayed late in 
infection (i.e. day 35 p.i.), presumably after initial control of the infection has been 
established. Consistent with this observation, impaired clearance has been documented in 
p40-deficient mice when compared with IL-12p35-/- mice following Francisella tularensis 
infection (ELKINS et al. 2002). In a very recent report on chronic Mycobacterium 
tuberculosis infection, IL-23p19-/- mice show an elevated bacterial burden in the spleen only 
at a late time point (KHADER et al. 2005). 
Notably, the differences observed in WT versus IL-23p19-/- mice following C. neoformans 
infection are not as pronounced as those seen comparing IL-12p35-/- and p40-deficient mice 
(DECKEN et al. 1998). Therefore, the protective capacity of IL-23 is more apparent in the 
absence of IL-12, as is the case for T. gondii and M. tuberculosis infection (LIEBERMAN et 
al. 2004; KHADER et al. 2005). It was shown that IL-12 inhibits IL-23 induced T cell 
production of IL-17 (AGGARWAL et al. 2003). Moreover, two reports demonstrate an 
enhancement of IL-23 effects in IL-12-deficient mice (IL-12p35-/- mice) in autoimmune 
DISCUSSION 
 - 69 - 
chronic inflammation (CUA et al. 2003; MURPHY et al. 2003). The subtle effects of IL-23 
in the presence of IL-12 in the model of C. neoformans infection could therefore be due to 
suppression of IL-23 functions by endogenous IL-12/IFN-γ by a yet unknown mechanism. 
 
5.2.2 Endogenous IL-23 contributes to maintenance of the granulomatous reaction 
In the chronic phase of infection, a granulomatous inflammatory response predominantly 
characterized by mononuclear cells is an important feature of resistance to C. neoformans 
infection (CASADEVALL and PERFECT 1998). As previously reported, p40-deficient mice 
show a defect in granuloma formation that was not observed in IL-12p35-/- mice (DECKEN 
et al. 1998). These findings are consistent with other reports on p40-dependent, IL-12-
independent defects in granuloma formation during infection with Salmonella Enteritidis or 
M. bovis BCG (HOLSCHER et al. 2001; LEHMANN et al. 2001). Of note, in all of these 
studies p40-dependent granuloma formation was explored in mice lacking IL-12. In the 
present study it showed that the lack of IL-23 leads to impaired granuloma formation even in 
the presence of IL-12. These findings are supported by a recent study using a murine model 
of tuberculosis. Reconstitution of M. tuberculosis-infected p40-deficient mice with 
recombinant IL-12 only partially restored their ability to form granulomata (FENG et al. 
2005). Granulomata were fewer in IL-12-reconstituted p40-deficient mice than in WT 
controls suggesting that IL-12 contributes in parts to granuloma formation and that other 
factors such as IL-23 are likely required for a sustained granulomatous inflammatory 
response (FENG et al. 2005). Indeed, the higher susceptibility to disease observed in 
p40-deficient mice when compared to IL-12p35-/- mice was associated with an impaired 
granuloma formation in the former genotype (HOLSCHER et al. 2001). In mice competent 
for IL-12 production, however, the specific lack of IL-23 did not affect granuloma formation 
in M. tuberculosis infection pointing to a more crucial role of IL-12 in this infection model 
(KHADER et al. 2005). IL-23 was shown to be responsible for the higher resistance to 
murine tuberculosis observed in IL-12p35-/- mice compared to p40-deficient mice and was 
demonstrated to induce IFN-γ in the absence of IL-12 in M. tuberculosis infection (KHADER 
et al. 2005). In C. neoformans infection, however, IL-12p35-/- similarly as p40-deficient mice 
fail to produce IFN-γ  and mount a Th2 response (DECKEN et al. 1998). Although neither in 
the presence nor in the absence of IL-12 IL-23 was shown to induce IFN-γ  in C. neoformans 
infection, in both cases granuloma formation is impaired by IL-23 deficiency. Collectively 
these data indicate that dependent on the nature of the infectious agent IL-23 can contribute 
to granuloma formation by means distinct from IL-12 and IFN-γ. 
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After initially being able to form hepatic granulomata with a frequency comparable to WT 
mice, at a later time point the granulomatous reaction was significantly impaired in 
IL-23p19-/- mice. Consistent with this data, in EAE, a mouse model of multiple sclerosis, 
susceptible WT and resistant IL-23p19-/- mice initially show comparable leukocyte 
infiltration into the brain, whereas sustained inflammation of the CNS is only seen in WT 
mice (CUA et al. 2003). Similarly, the magnitude of DTH response in IL-23p19-/- mice 
immunized with methylated BSA was comparable to WT mice at 18 hrs post induction but 
greatly diminished thereafter (GHILARDI et al. 2004). In summary, such findings point to a 
crucial role for IL-23 in the maintenance of inflammatory processes. 
 
5.2.3 IL-23 enhances the inflammatory process by induction of chemokines 
C. neoformans shows a strong tropism for the CNS where it causes a sustained 
meningoencephalitis with subsequent death if untreated (CASADEVALL and PERFECT 
1998). Therefore, the immune response in the brain is of particular interest. Aggregates of 
C. neoformans accumulate in the brain of WT and IL-23p19-/- mice, eliciting an inflammatory 
response in both genotypes. In IL-23p19-/- mice, however, the density of inflammatory 
infiltrates was reduced as compared to WT mice. Numbers of T cells, macrophages and 
neutrophils were significantly reduced. Interestingly, MCP-1 mRNA and protein 
concentrations were markedly lower in IL-23p19-/- mice. MCP-1 is a CC type chemokine that 
mainly attracts mononuclear leukocytes (LU et al. 1998). In pulmonary cryptococcosis, 
MCP-1 has been shown to be crucial for recruitment of CD4+ T cells and macrophages, 
production of TNF-α and IL-6, and clearance of organisms (HUFFNAGLE et al. 1995). Also, 
it has been described to be present at elevated levels in brains of mice protectively 
immunized against C. neoformans (UICKER et al. 2005). The role of IL-23 in the 
maintenance of inflammatory processes might therefore partially rely on cell recruitment via 
induction of MCP-1. 
 
5.2.4 IL-23 augments antigen presentation thereby maintaining the cellular response 
It was shown in this study that MHC-II expression in microglial cells was impaired in 
IL-23p19-/- mice when compared to WT controls. Also, 5-fold more MHC-II mRNA was 
induced in brains of WT than in IL-23p19-/- mice (data not shown). Similar observations have 
been described for EAE (CUA et al. 2003). Moreover, a role for IL-23 in enhancing antigen 
presentation has previously been shown for DCs (KOPP et al. 2003; BELLADONNA et al. 
2002). Since primed effector T cells are retained at the site of infection if antigen is 
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encountered in proper MHC context, the above findings describe another IL-23-dependent 
mechanism leading to the maintenance of localized immune responses. 
Although infected IL-23p19-/- mice show an impaired inflammatory response in the brain, 
the organ burdens do not significantly differ from WT controls. Previously it was reported 
that IL-12 deficiency leads to severely reduced survival times after C. neoformans infection, 
but organ burdens at day 21 p.i. in multiple organs including the brain did not differ between 
IL-12p35-/- mice and resistant WT controls (DECKEN et al. 1998). Therefore, in this model 
of cryptococcosis the fungal organ burden found relatively early in the course of cryptococcal 
infection is not necessarily predictive for the level of resistance as determined by survival 
time.  
 
5.2.5 The IL-23 induced cytokine pattern is hallmarked by IL-17, IL-6 and IL-1β  
In the present work it is shown, that the lack of IL-23 does not affect the Th1/Th2 balance. 
These data are consistent with findings in other studies looking at IL-23p19-/- mice in 
autoimmune disease or infection models (CUA et al. 2003; LIEBERMAN et al. 2004; 
MURPHY et al. 2003; KHADER et al. 2005) and resemble the previously reported finding 
that IL-12p35-/- and p40-deficient mice do not differ in IFN-γ production following 
C. neoformans infection (DECKEN et al. 1998). Interestingly, however, pronounced IL-17 
expression in WT but none in IL-23p19-/- mice could be observed. It is intriguing that 
antigen-specific production of IL-17 seems to be completely dependent on IL-23, whereas 
polyclonal stimulation of C. neoformans-infected splenocytes of IL-23-deficient mice led to 
the production of IL-23-independent IL-17, albeit to a lower level than seen in WT 
splenocytes after polyclonal stimulation. 
Because IL-23p19-/- mice produce less IL-17 it is conceivable that IL-17 acts as a mediator 
of IL-23. Herein reported is the observation of impaired expression of myeloid cell-derived 
proinflammatory cytokines such as IL-6 and IL-1β during cryptococcal infection of 
IL-23p19-/- mice. Of note, increased expression of IL-1β and TNF-α in the brains of infected 
WT mice is associated with protective immunity in cryptococcosis (UICKER et al. 2005). 
Indeed IL-17 was shown to stimulate production of TNF-α and IL-1β in human macrophages 
(JOVANOVIC et al. 1998). In addition, it promotes production of MCP-1 in various adherent 
cells (AGGARWAL and GURNEY 2002). A protective role for the IL-23/IL-17 axis has 
been defined in acute Klebsiella pneumoniae infection. IL-23-induced IL-17 was shown to be 
crucial for neutrophil recruitment to the infected airways and subsequent clearance of 
pathogen (HAPPEL et al. 2003; YE et al. 2001b). In a model of chronic M. tuberculosis 
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infection, IL-23p19-/- mice showed, consistent with the herein reported findings, a severe 
defect in antigen-specific IL-17 production that was, however, not associated with altered 
resistance to infection in these mice (KHADER et al. 2005). In the light of the above 
described predominant contribution of IFN-γ  to cellular responses in tuberculosis, IL-17 
effects might be completely obliterated by the IL-12/IFN-γ  axis. In C. neoformans infection 
IL-23 induced expression of IL-1β, IL-6 and MCP-1 in infected brains but no detectable 
IL-17. Therefore, direct effects of IL-23 on macrophages could be considered. Indeed, 
macrophages have been shown to bear the IL-23R (PARHAM et al. 2002). Studies in IL-17-/- 
mice have to be performed to provide a deeper insight in the regulation of cellular responses 
by IL-23/IL-17 in C. neoformans infection. 
 
5.3 A PROTECTIVE ROLE FOR EXOGENOUS IL-23 IN C. NEOFORMANS INFECTION 
The polysaccharide capsule of C. neoformans biases the immune response towards a suitable 
environment for survival of the fungus by down-regulating the expression of 
proinflammatory mediators (BUCHANAN and MURPHY 1998). Due to such 
immunosuppressive capacities, in the herein employed lethal model of cryptococcosis, 
observations in mice deficient for proinflammatory cytokines such as IL-23 might reveal only 
a faint signature of the possible protective effects of such factors. Therefore, the 
administration of IL-23 as performed in the present work was likely to give a better insight in 
the mechanism of action employed by IL-23. In cryptococcosis, this methodical approach 
was used in the past for a broad range of cytokines such as IFN-γ, IL-12, G-CSF and IL-18 
(BAVA et al. 1995; DECKEN et al. 1998; KAWAKAMI et al. 1996; KAWAKAMI et al. 
1997; UCHIDA et al. 1992; ZHANG et al. 1997). 
 
5.3.1 IL-23 improves resistance to C. neoformans infection without inducing Th1 
As discussed in section 5.1, recombinant IL-23 enhanced the resistance to C. neoformans 
infection in the absence of IL-12. Further experiments showed that exogenous IL-23 is also 
capable of protecting mice that are competent in IL-12 production. The enhanced resistance 
of IL-23-treated mice to C. neoformans infection adds to the finding of reduced resistance in 
IL-23 deficiency. 
However, the observed effect by IL-23 is weaker than the protection observed after IL-12 
treatment. IL-12 is a potent mediator of resistance in C. neoformans infection. Treatment of 
infected mice with IL-12 completely protects those mice from death. The strong enhancement 
of Th1 cytokine production following such treatment shows the importance of this pathway 
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in immunity to C. neoformans. Similar protective effects could be demonstrated following 
IFN-γ (BAVA et al. 1995) or also IL-18 (KAWAKAMI et al. 1997) treatment of 
C. neoformans infected mice. IL-23 treatment, however, though protective, is not associated 
with an enhancement of Th1. Moreover, the IL-23 treated mice develop a Th2 response 
similar to mock treated control mice.  
In contrast to treatment with IL-23 or IL-12, administration of homodimeric p40 to wild-
type mice had a detrimental effect on disease outcome in WT mice (DECKEN et al. 1998). 
While it is was known that homodimeric p40 blocks IL-12-induced IFN-γ production on the 
receptor level (GILLESSEN et al. 1995), a recent study shows that also IL-23 effects are 
antagonized by homodimeric p40 (SHIMOZATO et al. 2006). In the light of such findings 
together with today’s knowledge about the novel IL-12 family members more defined studies 
on the controversially discussed pro- or anti-inflammatory role of homodimeric p40 should 
be performed. As a preparative step for such studies, a p40 protein purification was 
performed and described in the present work. A surprising result was the finding of a 90 kDa 
protein band which occurs in association with the Sf9 cell (p40)2 band. This band is 
detectable in a p40-specific Western blot (Figs. 22 and 24). Analysis of current literature on 
p40 showed, that this second band, which has not been explicitly described so far, also occurs 
in supernatant of p40-transfected CHO cells (HOLSCHER et al. 2001: Fig. 3). Since this 
band did not gain intensity during a time course experiment (data not shown), it is unlikely to 
be a degradation product, but rather a glycosylation variant of homodimeric p40. Follow-up 
experiments should focus on assessing the biological importance of this finding and might 
add to our understanding of the conflicting data on the physiological role of homodimeric p40 
in the interplay of IL-12 family cytokines. 
 
5.3.2 Exogenous IL-23 elicits antimicrobial effects 
The prolonged survival was accompanied by lower organ burden at the site of infection at an 
early time point as well as in infected organs later in the course of infection. Two other 
studies so far described an antimicrobial effect of endogenous IL-23 at the site of infection: 
In a model of pulmonary tuberculosis IL-23 administration into infected lungs by an 
adenoviral vector could significantly reduce the mycobacterial burden in this organ 
(HAPPEL et al. 2005b). Secondly, recombinant IL-23 reduced the parasite burden in the 
peritoneal cavity of p40 deficient mice infected with T. gondii (LIEBERMAN et al. 2004). 
These findings complement the observation of increased fungal burden in the IL-23p19-/- 
mice. Moreover, the IL-23 mediated reduction of fungal burden at day 8 post infection 
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provided a fruitful model for further investigations on the mechanisms underlying such 
antimicrobial effects. 
 
5.3.2 IL-23 produces a distinct cytokine pattern hallmarked by proinflammatory 
cytokines as well as IL-5 
Treatment with IL-23 led to the induction of proinflammatory cytokines. Interestingly, not a 
Th1 pattern was induced since up-regulation or enhanced production of IFN-γ could not be 
observed. In contrast, IL-17 production was markedly enhanced in the IL-23 treated group. 
Recently, the role for IL-23 in promoting a IL-17 producing T cell subset (AGGARWAL et 
al. 2003; CUA et al. 2003) which is meanwhile considered a Th cell lineage distinct from 
Th1 and Th2 (AGGARWAL et al. 2003; HARRINGTON et al. 2005) could be defined. 
Besides IL-17, this T cell subset (Th17) was shown to produce IL-6 and TNF-α, both of 
which were found in elevated levels in the study presented here. In addition, mice genetically 
engineered to overexpress p19 develop severe systemic inflammation accompanied by high 
serum levels of TNF-α and IL-1β, but not IFN-γ (WIEKOWSKI et al. 2001). A more recent 
study investigated the outcome of local overexpression of IL-23 in a pulmonary tuberculosis 
model. Paralleling the here presented findings, the reduced bacterial burden following IL-23 
transfer was associated with the enhanced expression of IL-17 (HAPPEL et al. 2005b).  
Interestingly, IL-23 treatment showed a clear association with elevated IL-5 expression. 
IL-5 is commonly known as a Th2 cytokine, leading to the maturation and recruitment of 
eosinophils (WELTMAN and KARIM 2000). Although in the present study consistently 
elevated levels of IL-5 were found, at the site of infection as well as in restimulated spleen 
cell cultures, no increase of eosinophil counts could be observed. HUFFNAGLE et al. (1998) 
showed by neutralization of IL-5 of mice with pulmonary C. neoformans infection that 
besides its crucial effects on eosinophil counts in infected lungs, IL-5 also played an 
important role in the recruitment of macrophages, T lymphocytes, and B lymphocytes to the 
infected site. Interestingly, neutralization of IL-5 did not affect neutrophil recruitment 
(HUFFNAGLE et al. 1998). Thus, IL-5 might play a more distinct role in cryptococcosis. 
Above findings underline the herein reported observations in IL-23 deficient mice and 
clearly demonstrate that IL-23 induces a cytokine pattern that is distinct from Th1 or Th2. 
Besides IL-17 as the major hallmarking cytokine, the IL-23 induced immune pathway is 
characterized by the expression of IL-1β, IL-6, TNF-α, IL-5 and MCP-1.  
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5.3.3 IL-23 enhances recruitment of inflammatory cells to the site of infection 
Independently of IL-12, the administration of IL-23 led to enhanced recruitment of 
inflammatory cells such as T cells, NK cells and DCs to the site of infection. The elevated 
numbers of T cells observed after treatment with recombinant IL-23 resemble findings in a 
recent study on pulmonary tuberculosis. The delivery of IL-23 into infected lungs by an 
adenoviral vector led to higher counts of activated CD4 positive cells in this organ (HAPPEL 
et al. 2005b). Transgenic overexpression of p19 led to multiorgan inflammation with an 
inflammatory infiltrate mainly consisting of lymphocytes, macrophages and neutrophils 
(WIEKOWSKI et al. 2001), paralleling the herein reported findings. Moreover, 
administration of IL-23 to C. neoformans-infected mice also increased the recruitment of 
DCs to the site of infection. DCs are the most effective APC for inducing CMI responses 
(BANCHEREAU et al. 2000). In cryptococcosis DCs were demonstrated to be involved in 
the induction of protective immunity (BAUMAN et al. 2000). More recently, their specific 
involvement in bridging innate and adaptive immunity during C. neoformans infection was 
even more defined by their non-redundant capability of inducing T cell responses to 
mannoproteins, major antigens of C. neoformans (MANSOUR et al. 2006). Effects of IL-23 
on DC recruitment were also found in mice engineered to coexpress p40 and IL-23p19 in 
keratinocytes. Expression of the transgene led to increased numbers of Langerhans cells in 
the skins of such mice (KOPP et al. 2003). Consistent with the herein reported finding of 
elevated CD86 expression in inflammatory macrophages, those cells showed a marked up-
regulation of costimulatory molecules.  
The effect on inflammatory cell recruitment observed after IL-23 treatment closely 
resembles the findings associated with endogenous IL-23 reported in section 4.2. Together 
these data clearly demonstrate a role for IL-23 in inflammatory cell recruitment / granuloma 
formation during C. neoformans infection. 
 
5.3.4 IL-23 treatment is effective even in the absence of T cells 
The importance of cells of the adaptive immune system in immunity against C. neoformans 
infection was convincingly demonstrated in SCID mice which lack T and B cells and are 
highly susceptible to cryptococcosis (HUFFNAGLE et al. 1991). SCID mice were first 
phenotypically described in the late 1980s and then found to have a genetic mutation at 
chromosome 16 leading to a defect of the ubiquitous DNA double-strand break repair 
machinery (HENDRICKSON 1993; JORGENSEN et al. 1995). During lymphocyte 
development DNA break repair systems are crucial for successful V(D)J recombination 
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defining the specificity of the antigen receptor. However, DNA breaks occur also in other cell 
types, so that the outcome of such a general mutation is hard to predict. The finding of the 
lymphocyte specific RAG proteins involved in V(D)J recombination and the availability of 
mice deficient for these DNA recombinases generated by targeted disruption of RAG1 or 
RAG2 provided a more specific tool to investigate the role of adaptive versus innate 
immunity. Mice deficient for RAG genes were used in this study and showed, as expected, a 
higher susceptibility to C. neoformans infection than WT mice (data not shown). However, 
treatment of infected RAG-deficient mice with IL-23 clearly elicited proinflammatory effects 
that also led to increased resistance. RAG-deficient mice, although lacking adaptive 
immunity, have a functional innate immune system. In terms of resistance to cryptococcal 
infection the most important of such cell types are DCs, macrophages and NK cells, while 
controversial data exists on the contribution of neutrophils to resistance or susceptibility in 
this infection (CASADEVALL and PERFECT 1998).  
Macrophages have been shown to be significant effector cells in immunity to 
C. neoformans (LEVITZ 1994). They are most efficiently activated by IFN-γ and TNF-α, 
major cytokines expressed during Th1 responses. Addition of TNF-α to C. neoformans 
infected macrophage cultures enhanced their phagocyitc activity drastically (COLLINS and 
BANCROFT 1992). In addition to such direct activation, NK cells have been shown to 
activate macrophages even in the absence of T cells (KAWAKAMI et al. 2000). Addition of 
IL-12 or IL-18 increased this bystander activity of NK cells in vitro (KAWAKAMI et al. 
2000).  
Collectively, these data point to two possible mechanisms of action for exogenous IL-23 in 
RAG-deficient mice: (i) IL-23 directly activates macrophages, and (ii) IL-23 activates cells, 
such as NK cells, which then produce factors activating macrophages. Both hypotheses find 
support in the literature. Parham et al. showed that message for the IL-23R is expressed not 
only on T cells but also on macrophages and NK cells (PARHAM et al. 2002). Granulocytes 
have been shown to produce IL-17 (FERRETTI et al. 2003), whereas yet it is not known if 
those cells also express the IL-23 receptor. Moreover, we still lack clear evidence for a direct 
effect of IL-23 on cells of the innate immune system. In vitro, stimulation of murine bone-
marrow-derived macrophages did not lead to detectable cytokine production or regulation of 
cell surface proteins (unpublished data). In vivo, CUA et al. showed an effect on peritoneal 
macrophages by injecting rIL-23 in the peritoneal cavity of mice. Peritoneal macrophages 
obtained by peritoneal lavage were shown to express higher mRNA levels for IL-1β and 
TNF-α. Although strongly resembling the results obtained following intraperitoneal 
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application of IL-23 into RAG-deficient mice, those experiments were performed in T cell 
competent mice, still leaving open the possibility of an indirect effect on the peritoneal 
macrophages by T cell expressed factors, e.g. IL-17. 
Thus, although the induction of Th17 cells is clearly an important and exclusive function 
of IL-23 and is observed during C. neoformans infection, yet undefined T cell-independent 
effects of IL-23 can elicit an antifungal inflammatory environment.  
 
5.4 CONCLUSIONS 
Taken together, IL-23 complements the more dominant role of IL-12 in protection against 
C. neoformans by mechanisms distinct from IL-12. The IL-23 pathway is characterized by 
the promotion of IL-17, as well as IL-1β, IL-6, TNF-α and MCP-1, all of which affect cell 
recruitment and maintenance of inflammatory responses (Fig. 26). 
However, while in models of organ-specific autoimmunity the proinflammatory effects of 
IL-23 are crucial for disease progression, the contribution of endogenous IL-23 to the 
protective inflammatory response in this chronic fungal infection is limited. In contrast, in 
models of acute Klebsiella pneumoniae and Toxoplasma gondii infection, as well as in a 
murine model of sepsis IL-23 and/or IL-17 were shown to play a crucial role by inducing a 
protective neutrophil response (HAPPEL et al. 2005a; KELLY et al. 2005; RICE et al. 2005). 
This gives a clue to a physiological protective role for IL-23 and could be the basis for its 
evolutionary preservation. However, the in the present study reported findings clearly show a 
proinflammatory effect of IL-23 involving cells others than neutrophils, pointing to a more 
versatile role for IL-23 that still needs to be further defined.. 
Treatment with IL-23 shows a protective effect even in severely immunocompromised 
mice infected with C. neoformans. The lack of T cells as in RAG-deficient mice or that of 
Th1 responses as in p40-deficient mice resemble the situation of an AIDS patient; a high risk 
scenario for a cryptococcal infection. Current treatment with amphotericine B reduces 
mortality drastically; however, it leads to severe liver damage in the course of the inevitable 
long-term treatment regimen. Although in this context a supportive immunotherapy would be 
truly beneficial, for long-term IL-23 treatment the risk of developing autoimmune disorders 
cannot be ruled out.  
A more fruitful approach might be the development of IL-23 antagonists. IL-23 advanced 
to a most promising target for the treatment of organ-specific autoimmune diseases, such as 
psoriasis or rheumatoid arthritis. Currently, TNF-α antagonists are used for the treatment of 
rheumatoid arthritis; antibodies against p40 were found to be beneficial in psoriasis 
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treatment. Both such therapies, though highly efficacious, are associated with an elevated risk 
for infections as seen in AIDS patients. Particularly opportunistic chronic infections such as 
tuberculosis, histoplasmosis or cryptococcosis are reported (HAGE et al. 2003; RYCHLY 
and DIPIRO 2005; TRUE et al. 2002). Moreover, cases of neoplasias were observed in 
association with anti-p40 treatment of psoriasis or Crohn’s Disease (KAUFFMAN et al. 
2004; MANNON et al. 2004). Novel drugs have to be more specific in their inhibition of 
autoimmune inflammation without affecting immunity to infections and cancer; drugs that 
antagonize IL-23 might lead to this goal. 
The herein reported findings not only present an important contribution to the 
understanding of the biological function of IL-23, but also give important input for potential 





Fig. 26. Mechanism of action for IL-23 versus IL-12 in immunity to C. neoformans 
infection. IL-23 and IL-12 employ distinct mechanisms which result in activation of 
macrophages and subsequent elimination of C. neoformans organisms. 
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The interleukin (IL)-12 family of cytokines plays a key role in the orchestration of cellular 
immune responses, bridging innate and adaptive immunity. The founding member, IL-12, 
was discovered in the late 1980s as the first heterodimeric cytokine, composed of a 40 kDa 
(p40) and 35 kDa (p35) subunit. Years of basic and clinical research on this prototypical T 
helper type (Th)1 cytokine revealed its importance in immunity to intracellular non-viral 
infections, as well as in cancer and autoimmune diseases. Since the discovery of IL-23 as 
another cytokine composed of the p40 subunit of IL-12 in the year 2000, IL-23, rather than 
IL-12, could be shown to be the key player in rodent models of autoimmune diseases such as 
multiple sclerosis and rheumatoid arthritis. With accumulating evidence revealing IL-23 as 
the crucial regulator of a non-classical pathway of cellular immunity which is hallmarked by 
IL-17 producing T cells it is intriguing to gain understanding of the importance of such 
findings in immunity to infections. The present work describes a series of in vivo studies 
investigating the role of endogenous as well as exogenous IL-23 in a murine model of 
chronic fungal infection, cryptococcosis. 
To address the role of endogenous IL-23, wild-type (WT), IL-12- (IL-12p35-/-), IL-23- 
(IL-23p19-/-) deficient, as well as IL-12- and IL-23- double deficient (p40-deficient) mice on 
a C57BL/6 background were infected with Cryptococcus neoformans (C. neoformans). 
Following infection, p40-deficient mice demonstrated higher mortality than IL-12p35-/- mice. 
Reconstitution of p40-deficient mice with recombinant murine IL-23 prolonged their survival 
to levels similar to IL-12p35-/- mice. IL-23p19-/- mice showed a moderately reduced survival 
time and delayed fungal clearance in the liver. While interferon (IFN)-γ production was 
similar in WT and IL-23p19-/- mice, production of IL-17 was strongly impaired in the latter. 
IL-23p19-/- mice produced fewer hepatic granulomata relative to organ burden and showed 
defective recruitment of mononuclear cells to the brain. Moreover, activation of microglia 
cells and expression of IL-1β, IL-6, and MCP-1 in the brain was impaired.  
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The second part of the present work explores the mechanisms underlying the IL-23 effects by 
characterizing the role of exogenous IL-23. C. neoformans-infected C57BL/6 WT mice 
treated with recombinant murine IL-23 showed significantly prolonged survival time as 
compared to mock-treated control mice. However, complete survival throughout the 
observation period (100 days) was only achieved following IL-12 treatment. At day 21 post 
infection (p.i.) the IL-23-treated mice as well as the IL-12 group had a significantly lower 
fungal burden in the brain than the control mice. However, while IL-12 treatment was 
associated with elevated serum levels of the proinflammatory mediators IFN-γ, tumor 
necrosis factor (TNF)-α and nitric oxide, IL-23-treated animals, although more resistant, 
developed a Th2 response similar to the control group as measured by serum IgE levels. 
Further experiments to assess the mechanism of action were based on the finding of reduced 
fungal burden at the site of infection, the peritoneal cavity, at day 8 p.i. following IL-23 
treatment. This microbicidal effect was also seen in p40-deficient as well as in T and B cell 
deficient (RAG-deficient) mice. Administration of IL-23 led to enhanced recruitment of 
inflammatory cells, not only of T cells but also cells of the innate immune system such as 
DCs, natural killer cells and granulocytes to the infected site. Although numbers of 
macrophages were not altered following IL-23 treatment, co-stimulatory molecules were 
markedly up-regulated on such cells. The chemokine/cytokine pattern induced by IL-23 
treatment was hallmarked by proinflammatory mediators such as MCP-1, IL-1β, IL-6, TNF-α 
and IL-17, but also the Th2 associated cytokine IL-5. 
From these results it can be concluded that a non-classical immune pathway induced by 
IL-23 complements the more dominant role of IL-12 in protection against C. neoformans. 
This novel immune response is characterized by an enhancement of the inflammatory cell 
response and the production of a proinflammatory cytokine pattern hallmarked by IL-1β, 
IL-6, TNF-α and IL-17.  
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7 ZUSAMMENFASSUNG 
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In der zellulären Immunantwort kommt den Zytokinen der Interleukin (IL)-12 Familie eine 
Schlüsselrolle als Bindeglied zwischen angeborener und adaptiver Immunität zu. IL-12 
wurde erstmals in den späten 1980er Jahren als proinflammatorisches Zytokin beschrieben, 
das aus einer 40 kDa (p40) und einer 35 kDa (p35) Proteinuntereinheit zusammengesetzt ist. 
Mittlerweile konnte seine Rolle als prototypisches Zytokin der Typ-I Immunantwort und 
somit seine wichtige Funktion in der Immunabwehr gegen nicht-virale intrazelluläre 
Infektionen sowie bei Krebs und Autoimmunität definiert werde. Seit der Entdeckung von 
IL-23 als weiterem heterodimeren Zytokin, welches aus der p40 Untereinheit von IL-12 und 
der IL-23-spezifischen Untereinheit IL-23p19 besteht, konnte gezeigt werden, dass eher 
IL-23 als IL-12 eine essentielle Rolle in Nager-Modellen für Autoimmunerkrankungen wie 
Multipler Sklerose und Rheumatoider Arthritis zukommt. Mit wachsender Evidenz für einen 
durch IL-23 induzierten nicht-klassischen Arm der zellulären Immunantwort, der 
gekennzeichnet ist durch IL-17, stellt sich die Frage nach seiner Relevanz in der 
Wirtsabwehr. In der vorliegenden Arbeit wurde in einer Reihe von in vivo Experimenten die 
Rolle von endogenem sowie exogenem IL-23 am Mausmodell einer chronischen 
Pilzinfektion, der Kryptokokkose, untersucht. 
Zur Untersuchung von endogenem IL-23 wurden Wildtyp (WT), IL-23- (IL-23p19-/-) und 
IL-12- (IL-12p35-/-) defiziente sowie IL-12- und IL-23- doppelt-defiziente (p40-defiziente) 
C57BL/6 Mäuse mit Cryptococcus neoformans (C. neoformans) infiziert. Nach Infektion 
zeigten p40-defiziente Mäuse eine erhöhte Mortalität verglichen mit IL-12p35-/- Mäusen. 
Rekonstitution der p40-defizienten Tiere mit rekombinantem IL-23 führte zu einem 
verlängerten Überleben vergleichbar mit IL-12p35-/- Tieren. IL-23p19-/- Mäuse zeigten mäßig 
reduzierte Überlebenszeiten sowie eine verzögerte Erreger-Eliminierung in der Leber. 
Während der Interferon (IFN)-γ-Spiegel in WT und IL-23p19-/- Mäusen vergleichbar war, 
war die Produktion von IL-17 in IL-23p19-/- Mäusen deutlich vermindert. Relativ zur 
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Keimlast bildeten IL-23p19-/- weniger Granulome als WT Mäuse. Des Weiteren war die 
Rekrutierung von Entzündungszellen ins Gehirn sowie die Aktivierung von Microgliazellen 
in der Abwesenheit von IL-23 vermindert. Zudem war in diesen Tieren die Expression von 
IL-1β, IL-6 und MCP-1 verringert. 
Im zweiten Teil der vorliegenden Arbeit wurde die Rolle von exogenem IL-23 in der 
Kryptokokkose untersucht und somit die Mechanismen, die den IL-23-Effekten 
zugrundeliegen naeher untersucht. C. neoformans-infizierte C57BL/6 WT Mäuse, die mit 
rekombinantem IL-23 behandelt wurden, zeigten gegenüber den Kontrolltieren signifikant 
verlängerte Überlebenszeiten. 100%iges Überleben während des gesamten 
Beobachtungszeitraumes (100 Tage) konnte jedoch nur mit einer IL-12-Behandlung erzielt 
werden. An Tag 21 post infectionem (p.i.) zeigte sich eine Reduktion der Keimlast im Gehirn 
in der IL-12- sowie in der IL-23-behandelten Gruppe. Während die IL-12-Behandlung mit 
erhöhten IFN-γ, Tumor Nekrose Faktor (TNF)-α und Stickstoffmonoxid (NO) Serumspiegeln 
einherging, entwickelten IL-23-behandelte Tiere trotz der erhöhten Resistenz eine Th2-
Antwort (gemessen am IgE Serumspiegel) vergleichbar mit den Kontroll-behandelten Tieren. 
IL-23-Behandlung von WT Mäusen führt zu einer Reduktion der Keimlast am Ort der 
Infektion, der Peritonealhölhle, an Tag 8 p.i. Dieser Effekt zeigte sich unabhängig von IL-12 
in p40-defizienten Mäusen sowie in T- und B-Zell-defizienten (RAG-defizienten) Mäusen. 
Gabe von IL-23 führte zur verstärkten Rekrutierung von T-Zellen sowie Zellen der 
angeborenen Immunität wie z. B. dendritischen Zellen, natürlichen Killerzellen und 
Granulozyten zum Ort der Infektion. Obwohl sich kein Unterschied in der Anzahl von 
Makrophagen zeigte, führte IL-23 doch zu einer vermehrten Expression von ko-
stimulatorischen Molekülen auf diesen Zellen. Das durch IL-23 induzierte Zytokinmuster 
zeigt die charakteristische erhöhte Produktion von proinflammatorischen Mediatoren wie 
MCP-1, IL-1β, IL-6, TNF-α und IL-17, aber auch des Th2-Zytokins IL-5. 
Aus diesen Ergebnissen läßt sich schlußfolgern, daß eine nicht-klassische Immunantwort 
induziert durch IL-23 die dominantere Rolle von IL-12 in der Immunität gegen 
C. neoformans komplementiert. Charaktaristisch für diese Immunantwort ist eine verstärkte 
Entzündungszellrekrutierung sowie ein proinflammatorisches Zytokinmuster welches 
hauptsächlich durch IL-1β, IL-6, TNF-α und IL-17 geprägt ist. 
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